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A b s t r a c t — T h e intramolecular 1,3-dipolar cycloaddition of unsaturated nitrones derived from methyl a-D-glucopyranoside with 
2-furaldehyde has been studied. This cycloaddition was found to afford three 9-oxa- l -azabicyc lo[4 .2 .1]nonane diastereomers in a 3:1:1 
ratio [with the principal isomer possessing a (3S,4R,5S,6S,8S) configuration, determined by NMR spectroscopy]. The effects of different 
Lewis acid catalysts (MgCl 2 , ZnCl2 and B F 3 O E t 2 ) on yields and diastereomeric ratios have been examined in detail. The best result (90% 
yield) was achieved when MgCl 2 was present (in toluene, 120 °C bath temperature, 12 h). The stereoselectivity of the 1,3-dipolar 
cycloaddition was not significantly altered under the conditions investigated. 
© 2 0 0 5 Elsevier Ltd. All rights reserved. 
1. Introduction 
Peptide nucleic acids (PNAs) are nucleic acid mimics 
bearing a pseudopeptide backbone (Fig. I).1'2 They possess 
very favourable hybridisation properties with nucleic acid 
targets, display high chemical and biological stabilities and 
have the potential to be used as both antisense and antigene 
therapeutic agents. Unfortunately, PNA has low lipid 
penetration and, consequently, poor cellular uptake. In an 
attempt to overcome these undesirable attributes, we have 
designed a conformationally restricted oligonucleotide 
analogue whose backbone should be positively charged 
under physiological conditions. These new chiral nucleo-
side analogues are termed azetidine nucleic acids (ANAs, 
Fig. 1). The pivotal step in the synthesis of the ANA 
monomers, needed for construction of the oligomers, is a 
diastereoselective intramolecular 1,3-dipolar cycloaddition 
involving unsaturated nitrones derived from carbohydrate 
precursors. Subsequent transformations on the correspond-
ing isoxazolidines obtained should then afford the desired 
azetidine derivatives (Fig. 2). 
Keywords: 1,3-Dipolar cycloaddition; Isoxazolidines; Bicyclic 1,2-oxaze-
panes; 9-Oxa-l-azabicyclo[4.2.1]nonanes; Asymmetric synthesis. 
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We envisage that it will be possible to control the 
stereochemical outcome of the intramolecular 1,3-dipolar 
cycloaddition by virtue of steric constraint so that the actual 
number of isoxazolidine isomers produced would be 
reduced compared to the theoretical. The use of different 
Lewis acid catalysts is anticipated to improve both the 
stereoselectivity and reactivity of the nitrone. The mechan-
ism of such 1,3-dipolar cycloadditions has been extensively 
studied by several authors.3 Nitrones are nucleophiles which 
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Figure 1. The structure of PNA and ANA oligomers (B, nucleobase). Only 
one diastereoisomer is shown for each ANA structure. 
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Figure 2. Retrosynthetic analysis of ANA monomers. 
co-ordinate strongly to Lewis acids to form nitrone/Lewis 
acid complexes. These complexes are generated easily and 
they serve to assist in 1,3-dipolar cycloadditions through 
stabilization of the corresponding transition state and 
decreasing the energy gap between the LUMO and 
HOMO of one of the substrates.4'5 Thus, a series of 
catalysts (metals and their complexes) has been developed 
for use in either normal or inverse electron demand 1,3-
dipolar cycloadditions, for example, Mg 2 + , Ti2 + , Z n 2 + , 
N i 2 + , Pd , Yb3 + , B ( H I ) , Al3 + , CU 2 + . 3 The 1,3-dipolar 
cycloaddition of nitrones bearing heteroaryl rings with 
electron-deficient alkenes has been investigated in detail by 
Merino et al. 6 - 8 
Our interest in the development of an efficient route for the 
synthesis of chiral isoxazolidines and, ultimately, azetidines 
led us to therefore consider using a similar strategy, utilizing 
unsaturated nitrones derived from carbohydrates, for their 
preparation. The starting material employed for the work 
reported herein was methyl a-D-glucopyranoside (1) 
(Fig. 3). In this case, the 1,3-dipolar cycloaddition 
investigated was a model reaction in order that suitable 
reaction procedures for performing such cycloadditions 
could be identified. It is envisaged that future employment 
of appropriate carbohydrate derivatives from the D-manno 
and D-galacto series in place of 1 will permit formation of 
isoxazolidines in which the hydroxyl groups in the 
carbohydrate portion are differentiated. The preparation of 
such compounds is an integral part of our synthetic 
approach to the desired ANA monomers. 
2. Results and discussion 
The starting material, methyl a-D-glucopyranoside 1, was 
successfully converted into the benzoylated (2) and 
benzylated (9) 6-deoxy-6-iodo derivatives according to the 
methods described by Garegg9 and Vasella,10 respectively 
(Fig. 3). The subsequent Boord reaction on the halo 
derivatives [2—>3, 9—>10 (Fig. 3)] was accomplished 
upon treatment with zinc followed by sonication.11 
However, it was discovered that acceptable yields of the 
products 3 and 10 were only obtained for small scale 
OCH-J 
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Figure 3. a: (2—3, 9— 10): Zn, sonication (1.6 g scale: 90%, 5 g scale: 
30%) or Zn and Co(II)phthalocyanine (5 g scale: 70%), b: NH 2 0H HC1, 
NaHC03 (70%), c: NaBH3CN, HCVdioxane, d: 2-furaldehyde, toluene (c + 
d: 30-40%), 4 A MS, 50 °C, 18 h, e: toluene, 120 °C, 4 A MS, Lewis acid 
catalyst, 7: 9-oxa-l-azabicyclo-[4.2.1]nonane, 8: 8-oxa-l-azabicyclo-
[4.2.1]nonane skeletons. 
reactions (up to 1.6 g of 2 or 9 afforded 3 or 10 in ca. 90% 
yields). Thus, several attempts were made to increase the 
scale of this reaction by employing activated zinc instead. 
This was prepared according to established methods,13 for 
example, zinc-copper alloy14 or the reduction of anhydrous 
zinc chloride with various alkali metals in the presence of 
naphthalene.15-16 Heating solutions of 2 or 9 in ethanol at 
reflux in the presence of activated zinc produced by either 
method, afforded the same result, with respect to scale and 
yield (1 g scale ca. 70%, 5 g scale ca. 30% yield). When 
more than 5 g of the starting 6-deoxy-6-iodo derivative (2 or 
9, respectively) was used and the activated zinc was 
prepared in situ from zinc chloride and lithium, the reaction 
also failed to go to completion. In this case, though, the 
remaining lithium in the reaction mixture caused decompo-
sition of the unsaturated aldehyde and, also, prevented 
addition of water to the reaction mixture, which is necessary 
to dissolve zinc salts from the surface of zinc. Thus, all these 
procedures gave optimum product yields up to a maximum 
1 g scale. Upon conducting further investigations into this 
Boord reaction, we found that, for large scale reactions, 
reasonable yields of the products 3 and 10 could be obtained 
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when zinc and cobalt(II) phthalocyanine was utilised 
(Kleban et al.12 employed zinc and vitamin B I 2 for the 
same purpose) rather than zinc and sonication (5 g scale, ca. 
70% yield). 
Having prepared unsaturated aldehydes 3 and 10, the next 
step in our synthetic pathway involved treatment with 
hydroxylamine at room temperature17 to give oximes 4 and 
U , respectively (E/Z isomers in 1:1 ratio) (Fig. 3). 
Subsequently, 4 or l l 1 8 were reduced with sodium cyano-
horohydride and HC1/1,4-dioxane at the appropriate pH, 
depending on the protecting groups present, to afford 5 or 
12, respectively (Fig. 3). These hydroxylamines were used 
l n the next step without further purification in order to avoid 
their decomposition. The mixture of HC1/1,4-dioxane had to 
he added slowly due to the acid sensitive nature of the 
benzoyl protecting groups and because further reduction of 
the hydroxylamine could easily occur at low pH which 
would result in formation of the amine instead. It was 
envisaged that this amine by-product would hinder the 
subsequent condensation step as it could react with 
2-furaldehyde to give a SchifPs base, drastically reducing 
the yield of the cycloaddition reaction. Therefore, in an 
attempt to overcome this limitation, we have investigated 
Performing the reduction of 4 and 11 in phosphate buffer 
solutions at various pHs, ranging from 4 to 8. Unfortunately, 
to date, all attempts have proved unsuccessful and so our 
original approach for preparing hydroxylamines 5 and 12 
has been retained for the present work. Finally, crude 
hydroxylamines 5 and 12 were condensed with 2-furalde-
hyde to furnish the desired nitrones, 6 and 13, required for 
investigation of the 1,3-dipolar intramolecular cyclo-
addition reaction (Fig. 3). These were afforded in overall 
yields of 30-40% for the two steps, after purification. 
With nitrones 6 and 13 to hand, it was now possible to 
investigate the intramolecular 1,3-dipolar cycloaddition. 
This was simply accomplished by heating a solution of the 
appropriate nitrone in toluene at reflux in the presence of 4 A 
molecular sieves (Fig. 3). Unfortunately, for the benzyl 
protected nitrone 13, this reaction proved to be sluggish 
(toluene, reflux, 1 week) and very low yielding (<10%); 
therefore it was abandoned. For the benzoyl nitrone 6, this 
reaction was found to be more successful and gave 
isoxazolidine 7 (Fig. 3) as a mixture of diastereoisomers 
in 17-90% yield as expected. These isomers were 
subsequently separated by column chromatography and 
characterised by NMR spectroscopy as the 9-oxa-l-
azabicyclo[4.2.1]nonane diastereoisomers 7b-7d (Fig. 4). 
We were unable to isolate the fourth diastereisomer from the 
9-oxa series (7a) (Fig. 4) as its yield was negligible. We 
assume that the other alternative product from this 
cycloaddition, 8-oxa-l-azabicyclo[4.2.1]nonane 8 (Fig. 3), 
did not form because of steric hindrance between the furyl 
side chain and the oxazepane ring. 
Tables 1 and 2 show selected proton and carbon chemical 
shifts recorded in the ^ and 13C NMR spectra of 
compounds 7b-7d. Upon assignment of the individual 
resonances by means of 1H, 13C, HSQC and HMBC NMR 
measurements, it was shown that protons H-6 and H-8 adopt 
a relative trans arrangement in the principal isomer 7b 
O V H 
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Figure 4. The structures of 9-oxa-l-azabicyclo[4.2.1]nonanes 7a-7d 
whereas the equivalent protons in isomers 7c and 7d assume 
a cis arrangement. The NOESY spectrum of 7b (Fig. 5) 
indicates the spatial proximity of protons H-2a, H-4, and H-
8 and that of H-7b, H-4, H-8. Protons H-7b and H-2a reside 
on the bottom face of the structure relative to the oxazepane 
ring. In addition, it appears that proton H-7b is located far 
from its neighbours, H-2a, H-4 and H-8, as no coupling 
between H-7b and H-2a was detected (Table 4). 
Table 1. Selected 'H NMR chemical shifts of compounds 7b-7d 
Compound/ 
atom 
H-2a (dd)a 
H-2b (dd) 
H-3 
H-4 (dd) 
H-5 
H-6 
H-7a (ddd) 
H-7b (ddd) 
H-8 (dd) 
H-3'(d) 
H-4'(dd) 
7b 7c 
3.22 3.60 
4.22 2.89 
5.85 (m) 5.96 (ddd) 
6.00 6.21 
5.68 (dd) 5.51 (d) 
5.02 (m) 4.82 (dd) 
2.75 2.83 
3.18 3.14 
4.63 4.74 
6.28 6.60 
6.32 6.44 
7d 
3.02 
3.53 
5.89 (ddd) 
5.98 
5.69 (dd) 
4.96 (ddd) 
2.67 
2.86 
4.71 
6.51 
6.42 
1 Multiplicities in parenthesis. 
Table 2. Selected 13C NMR chemical shifts of compounds 7b-7d 
7b 7c 7d Compound/ 
atom 
C-2 
C-3 
C-4 
C-5 
C-6 
C-7 
C-8 
C-2' 
C-3' 
C-4' 
C-5' 
58.7 
68.8 
73.1 
73.1 
77.7 
34.2 
65.4 
154.3 
106.2 
110.3 
142.3 
54.7 
68.1 
74.7 
79.2 
81.8 
38.1 
60.9 
147.1 
111.2 
110.8 
143.6 
52.2 
66.8 
74.6 
73.2 
77.6 
31.2 
64.1 
148.1 
111.1 
110.7 
143.4 
n 
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Figure 5. NOESY spectrum of compound 7b. Crucial correlations between 
underlined protons are shown in boxes. 
Table 3. Coupling constants for compounds 7b-7d (Hz) 
Compd/coupling 7b 7c 7d 
constant 
Aa,2b 13.8 15.0 12.5 
h „3 7.9 10.9 10.3 
Ab.3 4.9 4.0 4.0 
h.A 9.2 10.9 10.1 
A.S 7.9 7.6 8.7 
A.« 6.0 — 5.8 
J6,11 8.8 6.1 8.7 
A. 7b 3.8 10.0 6.2 
17a, 7b 13.1 13.5 13.2 
Aa, 8 3.6 11.0 7.2 
Ab.8 8.5 9.5 11.2 
A',4' 3.2 3.2 3.1 
A'. 5' 1.9 2.0 1.9 
Table 4 reveals that compounds 7b and 7d adopt similar 
structures. Naturally, though, the position of protons H-8 
and H-3' in the furyl ring are reversed for isomer 7d 
compared to isomer 7b [7b: (85), 7d: (8/?)]. This was 
confirmed by the coupling constants measured between 
protons H-6, H-7 and H-8 (Table 3). The only real difference 
between their structures is that proton H-7b is located closer 
to protons H-2a and H-4 in isomer 7d (evaluated from the 
dihedral angles). Thus, for isomer 7d, a cross-correlation 
peak was visible in the NOESY spectrum (H-7b/H-2a/H-4). 
In the case of isomer 7c, protons H-3'/H-3/H-7a and H-5/ 
H-3/H-7a on the top face of the oxazepane ring are found to 
be in close proximity to each other, according to the 
NOESY spectrum recorded. By taking into account the 
coupling constants for all the isoxazolidine and 1,2-
oxazepane ring protons in all three isomers, we have been 
able to determine the configuration of each of the newly 
formed chiral centres [7b: (65,85); 7c: (6R, 85); and 7d: 
(65,81?) (Fig. 4)]. The stereochemistry of the remaining 
chiral centres have been deduced from D-glucose and the 
conformation of the 1,2-oxazepane ring. 
The effects of different Lewis acid catalysts (BF3 • OEt2, ZnCl2, 
MgCl2), solvents, absence or presence of 4 A molecular 
sieves and reflux time on yields and diastereomeric ratios 
for this intramolecular 1,3-dipolar cycloaddition with 
nitrone 6 (Fig. 3) have been examined in detail (Table 5). 
The diastereomeric ratios of 7b-7d obtained from each 
reaction were initially determined by the combined use of 
TLC and RP-HPLC. However, as this method proved 
cumbersome and inaccurate, alternatives were sought. The 
fortunate finding that, in the H NMR spectra, the peaks 
assigned to protons H-3' and H-4' of the furyl ring were 
located in unique positions for each of the three isomers, 
that is, 7b-7d, led us to investigate using *H NMR 
spectroscopy instead for these measurements. This afforded 
ratios which were in good agreement with those obtained 
previously from RP-HPLC experiments and so, due to its 
convenience and accuracy, it became the method of choice. 
From Table 5, it can be seen that when the intramolecular 
1,3-dipolar cycloaddtion was performed in toluene, the 
reflux time (24 or 48 h) had no effect on yield or 
diastereomeric ratio. However, since nitrone 6 decomposed 
quickly at temperatures above 100 °C, even under an argon 
atmosphere, it was not advantageous to heat the reaction in 
toluene at reflux for more than 24 h. 1,4-Dioxane was found 
to be an unsuitable solvent for this reaction; the mixture of 
isomers 7b-7d was afforded in only 17% yield. 
We have established that the main diastereoisomer obtained 
from these cycloaddition reactions (except when 1,4-
dioxane and ZnCl2 was used) was 7b, bearing the (65,85) 
configuration at the newly formed chiral centres (Table 5). 
The maximum yield for this intramolecular 1,3-dipolar 
cycloaddition was achieved when MgCl2 was added [90%, 
toluene, 120°C (bath temperature), 12 h, Table 5]. 
Unexpectedly, in the presence of the harder Lewis acid 
catalyst, BF3 • OEt2, most of the starting nitrone 6 decom-
posed after only a few hours to give an undesired product 
which contained one less benzoyl group (as determined 
from MS data). As a result of this finding, we propose that 
this also attributed to the reduced yield observed for the 
reaction performed in the presence of ZnCl2, although here 
decomposition of the nitrone was slower. 
In conclusion, we have ascertained that the optimum 
conditions for performing this 1,3-dipolar cycloaddition 
Table 4. NOESY data of compounds 7b-7d 
Compd Connected protons (upside positions)" Connected protons (downside positions)* Connected protons (peripheral positions)* 
7b H-3---H-2b; H-5---H-6 H-7b• • • H-8 • • • H-4; H-8• • -H-2a- - • H-4 H-6---H-7a; H-7a -H-3' 
7c H-3'--H-3---H-7a H - 3 - H - 5 - H - 7 a H - 3 - H - 2 b H-2a---H-4 H-7b -H-8; H-7b -H-6 
7d H-3- -H-2b; H-5---H-6 H-7b -H-2a -H-4 -H-3' H-7a -H-6; H-7a -H-8 
* Relative to the 9-oxa-l-azabicyclo[4.2.1]nonane skeleton as shown in Figure 6. 
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Table S. The effect of Lewis acids and solvents on yields and diastereomeric ratios 
Solvent, mol 
sieves 
Catalyst Time (h) Temperature (°C)
a Yield (%) Diastereomeric 
ratios (HPLC)b 
Diastereomeric 
ratios (NMR)b-c 
Toluene, 4 Â 24 120 70 2.8:1:1 3:1:1 
Toluene 48 120 75 2.8:1:1.2 3:1:1 
Benzene, 4 A 24 80 32 2.1:1:1 2:1:1 
1.4-Dioxane, 4 A 24 100 17 1:1.1:1.2 d 
Toluene, 4 Â ZnCl2 24 120 50 4:1 : I
e 0.5:1:1 
Toluene, 4 Â MgCl2 12 120 90 2:1:1 2:1:1 
Toluene, 4 Â BF 3 OEt 2 24 120 — — — 
Bath temperature. 
Ratio of isomers 7b:7c:7d isolated from the reaction mixture. 
Determined from the integral of protons H-3' and H-4'. 
c Not determined due to the presence of impurities. 
Diastereomer 7b could not be separated from an impurity. 
The starting material decomposed and a by-product was formed (see text). 
reaction with nitrone 6 (Fig. 3) involve using toluene as the 
solvent and MgCl2 as the Lewis acid catalyst. It appears that 
if the Lewis acid catalyst added is hard, a side reaction 
involving elimination of a benzoyl protecting group from 
the starting nitrone becomes significant and this may be 
accompanied by decomposition and conversion of the fury] 
group, too. The stereoselectivity of the cycloaddition was 
found not to alter much under the conditions investigated 
here. 
3. Theoretical investigations 
In order to analyse the geometry of all four diastereoisomers 
of the isozaxolidine derivative (i.e., 7a-7d (Fig. 4)) 
produced from the intramolecular 1,3-dipolar cycloaddition 
with nitrone 6 (Fig. 3), we have conducted a systematic 
computational investigation. This involved performing 
molecular dynamics simulations followed by high-level ab 
initio calculations. For the molecular dynamics studies, the 
'simulated annealing' protocol described in the SYBYL 
program package19 was employed to obtain the required 
starting geometries for isomers 7a-7d for the subsequent 
higher level investigations. The Merck's force field 
parameter set (MMFF94) was applied with its own charge 
distribution. The molecules were equilibrated for 2000 fs at 
1200 K and then cooled to 50 K exponentially over 
10,000 fs. In this way, 1000 conformations were provided 
for each isomer. Next a semi-empirical optimization using 
the PM3 method was performed and the results afforded 
were grouped according to their energies. Finally, ab initio 
Figure 6. The lowest-energy conformation of compound 7b calculated by 
HF/3-21 method. Proximal hydrogen atoms of 9-oxa-l-azabicyclo[4.2.1]-
nonane skeleton, supporting the configuration and conformation of the 
above compound (NMR evidence), are shown with the H prefix. Carbon 
atoms of the above skeleton and those of the furan skeleton (primed 
numbers) are labelled without the C prefix for clarity. 
calculations were conducted on a representative for each of 
the different energy clusters. These utilised the Hartree-
Fock method with 3-21 Gaussian basis set and applied the 
Gaussian03 code.20 Although this is one of the simplest 
methods, it was reasoned that this was sufficient for our 
purposes. The conformations of the oxazepane rings for 
isomers 7b-7d derived from the computational studies were 
found to be in very good agreement with the structures 
obtained previously from NMR studies. In Figure 6, the 
optimized geometry of isomer 7b is presented. The 
spatial proximity of protons H-7b, H-8, H-4 and H-2a on 
the bottom face can be clearly seen. In addition to the 
theoretical calculations providing information about the 
geometry of isomers 7a-7d, we had hoped that they could 
also be used to predict the diastereomeric ratio afforded by 
the cycloaddition reaction (7a:7b:7c:7d = 0:3:l:l) based on 
the total energy of each of the isomers. 
However, it appeared that, at this level of theory, significant 
differences could not be observed with the total energies for 
diastereoisomers 7a-7d being approximately the same. In 
Table 6, the HF/3-21 G total energies of the minimized 
geometries for each of the different isozaxolidine isomers 
are presented. 
Table 6. Calculated total energies of compounds 7a-7da 
Compound Total energy (hartree) 
7a -1870 .388634 
7b -1870 .389014 
7c -1870 .389014 
7d -1870 .389272 
a Ab initio (HF/3-21 G method). 
4. Conclusion 
We have successfully synthesized a variety of isoxazolidine 
derivatives of chiral moieties employing a Lewis acid-
catalyzed 1,3-dipolar cycloaddition. In our preliminary 
studies, the exclusive formation of 9-oxa-l-azabicyclo-
[4.2.1]nonane diastereomers 7b-7d (Fig. 4) from nitrone 6 
(Fig. 3) has been observed. The maximum yield for the 1,3-
dipolar cycloaddition reaction was achieved with MgCl2 as 
the Lewis acid catalyst [toluene, 120 °C (bath temperature), 
12 h]. The ratio of the diastereoisomers of 7b-7d was 3:1:1 
and this did not alter significantly under the different 
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Figure 5. NOESY spectrum of compound 7b. Crucial correlations between 
underlined protons are shown in boxes. 
Table 3. Coupling constants for compounds 7b-7d (Hz) 
Compd/coupling 7b 7c 7d 
constant 
•frajb 13.8 15.0 12.5 
Jla.1 7.9 10.9 10.3 
32b.3 4.9 4.0 4.0 
h.i 9.2 10.9 10.1 
A , s 7.9 7.6 8.7 
Ji.t 6.0 — 5.8 
36Je 8.8 6.1 8.7 
36.1b 3.8 10.0 6.2 
3l a,7b 13.1 13.5 13.2 
3le.i 3.6 11.0 7.2 
3l b,8 8.5 9.5 11.2 
3y.f 3.2 3.2 3.1 
3«, s> 1.9 2.0 1.9 
Table 4 reveals that compounds 7b and 7d adopt similar 
structures. Naturally, though, the position of protons H-8 
and H-3' in the furyl ring are reversed for isomer 7d 
compared to isomer 7b [7b: (85), 7d: (8/?)]. This was 
confirmed by the coupling constants measured between 
protons H-6, H-7 and H-8 (Table 3). The only real difference 
between their structures is that proton H-7b is located closer 
to protons H-2a and H-4 in isomer 7d (evaluated from the 
dihedral angles). Thus, for isomer 7d, a cross-correlation 
peak was visible in the NOESY spectrum (H-7b/H-2a/H-4). 
In the case of isomer 7c, protons H-3'/H-3/H-7a and H-5/ 
H-3/H-7a on the top face of the oxazepane ring are found to 
be in close proximity to each other, according to the 
NOESY spectrum recorded. By taking into account the 
coupling constants for all the isoxazolidine and 1,2-
oxazepane ring protons in all three isomers, we have been 
able to determine the configuration of each of the newly 
formed chiral centres [7b: (65,85); 7c: (6/?,85); and 7d: 
(65,8/?) (Fig. 4)]. The stereochemistry of the remaining 
chiral centres have been deduced from D-glucose and the 
conformation of the 1,2-oxazepane ring. 
The effects of different Lewis acid catalysts (BF3 • OEt2, ZnCl2, 
MgCl2), solvents, absence or presence of 4 A molecular 
sieves and reflux time on yields and diastereomeric ratios 
for this intramolecular 1,3-dipolar cycloaddition with 
nitrone 6 (Fig. 3) have been examined in detail (Table 5). 
The diastereomeric ratios of 7b-7d obtained from each 
reaction were initially determined by the combined use of 
TLC and RP-HPLC. However, as this method proved 
cumbersome and inaccurate, alternatives were sought. The 
fortunate finding that, in the 'H NMR spectra, the peaks 
assigned to protons H-3' and H-4' of the furyl ring were 
located in unique positions for each of the three isomers, 
that is, 7b-7d, led us to investigate using 'H NMR 
spectroscopy instead for these measurements. This afforded 
ratios which were in good agreement with those obtained 
previously from RP-HPLC experiments and so, due to its 
convenience and accuracy, it became the method of choice. 
From Table 5, it can be seen that when the intramolecular 
1,3-dipolar cycloaddtion was performed in toluene, the 
reflux time (24 or 48 h) had no effect on yield or 
diastereomeric ratio. However, since nitrone 6 decomposed 
quickly at temperatures above 100 °C, even under an argon 
atmosphere, it was not advantageous to heat the reaction in 
toluene at reflux for more than 24 h. 1,4-Dioxane was found 
to be an unsuitable solvent for this reaction; the mixture of 
isomers 7b-7d was afforded in only 17% yield. 
We have established that the main diastereoisomer obtained 
from these cycloaddition reactions (except when 1,4-
dioxane and ZnCl2 was used) was 7b, bearing the (65,85) 
configuration at the newly formed chiral centres (Table 5). 
The maximum yield for this intramolecular 1,3-dipolar 
cycloaddition was achieved when MgCl2 was added [90%, 
toluene, 120 °C (bath temperature), 12 h, Table 5]. 
Unexpectedly, in the presence of the harder Lewis acid 
catalyst, BF 3 OEt 2 , most of the starting nitrone 6 decom-
posed after only a few hours to give an undesired product 
which contained one less benzoyl group (as determined 
from MS data). As a result of this finding, we propose that 
this also attributed to the reduced yield observed for the 
reaction performed in the presence of ZnCl2, although here 
decomposition of the nitrone was slower. 
In conclusion, we have ascertained that the optimum 
conditions for performing this 1,3-dipolar cycloaddition 
Table 4. NOESY data of compounds 7b-7d 
Compd Connected protons (upside positions)* Connected protons (downside positions)* Connected protons (peripheral positions)* 
7b H-3 -H-2b; H - 5 - H - 6 H-7b• • • H-8 • •• H-4; H-8 • H-2a- - H - 4 H-6 -H-7a; H-7a- H-3' 
7c H - 3 ' - H - 3 - H - 7 a H-3 - H - 5 - H - 7 a H - 3 - H - 2 b H - 2 a - H - 4 H-7b- H-8; H-7b- H-6 
7d H-3 -H-2b; H - 5 - H - 6 H-7b •• • H-2a- • H-4 • • • H-3 ' H-7a -H-6; H-7a- H-8 
a Relative to the 9-oxa-l-azabicyclo[4.2.1]nonane skeleton as shown in Figure 6. 
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Table 5. The effect of Lewis acids and solvents on yields and diastereomeric ratios 
Solvent, mol Catalyst Time (h) Temperature (°C)
a Yield (%) Diastereomeric Diastereomeric 
sieves ratios (HPLC)
b ratios (NMR)b"c 
Toluene, 4 Â 24 120 70 2.8:1:1 3:1:1 
Toluene 48 120 75 2.8:1:1.2 3:1:1 
Benzene, 4 Â 24 80 32 2.1:1:1 2:1:1 
1,4-Dioxane, 4 A — 24 100 17 1:1.1:1.2 d 
Toluene, 4 Â ZnCl2 24 120 50 4:1:1' 0.5:1:1 
Toluene, 4 Â MgCl2 12 120 90 2:1:1 2:1:1 
Toluene, 4 À BF3 • OEt2 24 120 — — 
a Bath temperature. 
b Ratio of isomers 7b:7c:7d isolated from the reaction mixture. 
c Determined from the integral of protons H-3' and H-4'. 
d Not determined due to the presence of impurities. 
' Diastereomer 7b could not be separated from an impurity. 
' The starting material decomposed and a by-product was formed (see text). 
reaction with nitrone 6 (Fig. 3) involve using toluene as the 
solvent and MgCl2 as the Lewis acid catalyst. It appears that 
if the Lewis acid catalyst added is hard, a side reaction 
involving elimination of a benzoyl protecting group from 
the starting nitrone becomes significant and this may be 
accompanied by decomposition and conversion of the furyl 
group, too. The stereoselectivity of the cycloaddition was 
found not to alter much under the conditions investigated 
here. 
3. Theoretical investigations 
In order to analyse the geometry of all four diastereoisomers 
of the isozaxolidine derivative (i.e., 7a-7d (Fig. 4)) 
produced from the intramolecular 1,3-dipolar cycloaddition 
with nitrone 6 (Fig. 3), we have conducted a systematic 
computational investigation. This involved performing 
molecular dynamics simulations followed by high-level ab 
initio calculations. For the molecular dynamics studies, the 
'simulated annealing' protocol described in the SYBYL 
program package19 was employed to obtain the required 
starting geometries for isomers 7a-7d for the subsequent 
higher level investigations. The Merck's force field 
parameter set (MMFF94) was applied with its own charge 
distribution. The molecules were equilibrated for 2000 fs at 
1200 K and then cooled to 50 K exponentially over 
10,000 fs. In this way, 1000 conformations were provided 
for each isomer. Next a semi-empirical optimization using 
the PM3 method was performed and the results afforded 
were grouped according to their energies. Finally, ab initio 
Figure 6. The lowest-energy conformation of compound 7b calculated by 
HF/3-21 method. Proximal hydrogen atoms of 9-oxa-l-azabicyclo[4.2.1]-
nonane skeleton, supporting the configuration and conformation of the 
above compound (NMR evidence), are shown with the H prefix. Carbon 
atoms of the above skeleton and those of the furan skeleton (primed 
numbers) are labelled without the C prefix for clarity. 
calculations were conducted on a representative for each of 
the different energy clusters. These utilised the Hartree-
Fock method with 3-21 Gaussian basis set and applied the 
Gaussian03 code.20 Although this is one of the simplest 
methods, it was reasoned that this was sufficient for our 
purposes. The conformations of the oxazepane rings for 
isomers 7b-7d derived from the computational studies were 
found to be in very good agreement with the structures 
obtained previously from NMR studies. In Figure 6, the 
optimized geometry of isomer 7b is presented. The 
spatial proximity of protons H-7b, H-8, H-4 and H-2a on 
the bottom face can be clearly seen. In addition to the 
theoretical calculations providing information about the 
geometry of isomers 7a-7d, we had hoped that they could 
also be used to predict the diastereomeric ratio afforded by 
the cycloaddition reaction (7a:7b:7c:7d = 0:3:1:1) based on 
the total energy of each of the isomers. 
However, it appeared that, at this level of theory, significant 
differences could not be observed with the total energies for 
diastereoisomers 7a-7d being approximately the same. In 
Table 6, the HF/3-21 G total energies of the minimized 
geometries for each of the different isozaxolidine isomers 
are presented. 
Table 6. Calculated total energies of compounds 7a-7d a 
Compound Total energy (hartree) 
7a -1870 .388634 
7b -1870 .389014 
7c -1870 .389014 
7d - 1 8 7 0 . 3 8 9 2 7 2 
a Ab initio (HF/3-21 G method). 
4. Conclusion 
We have successfully synthesized a variety of isoxazolidine 
derivatives of chiral moieties employing a Lewis acid-
catalyzed 1,3-dipolar cycloaddition. In our preliminary 
studies, the exclusive formation of 9-oxa-l-azabicyclo-
[4.2.1]nonane diastereomers 7b-7d (Fig. 4) from nitrone 6 
(Fig. 3) has been observed. The maximum yield for the 1,3-
dipolar cycloaddition reaction was achieved with MgCl2 as 
the Lewis acid catalyst [toluene, 120 °C (bath temperature), 
12 h]. The ratio of the diastereoisomers of 7b-7d was 3:1:1 
and this did not alter significantly under the different 
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reaction conditions investigated here. The theoretical total 
energies of the minimized geometries for 7a-7d obtained 
computationally failed to rationalise the experimentally 
determined diastereomeric ratios of these cycloadducts 
produced from the intramolecular 1,3-dipolar cycloaddition. 
Further studies are in progress to obtain chiral 1,2,4-
substituted azetidines from the cycloadducts afforded and 
new cycloaddition reactions are envisaged. 
5. Experimental 
5.1. General procedures 
The following abbreviations are employed: ACN (aceto-
nitrile); ANA (azetidine nucleic acid(s)); anh. (anhydrous); 
Bn (benzyl); Bz (benzoyl); CDC13 (deuterochloroform); 
CH2C12 (dichloromethane); ESI (electrospray ionization); 
EtOAc (ethyl acetate); FAB (fast atom bombardment); 
HRMS (high resolution mass spectrometry); LRMS (low 
resolution mass spectrometry); MeOD (deuteromethanol); 
MeOH (methanol); PNA [peptide nucleic acid(s)]; rt (room 
temperature); THF (tetrahydrofuran). 
Chemicals were purchased from Aldrich, Fluka, Merck or 
Reanal (Budapest, Hungary). 2-Furaldehyde and BF 3OEt 2 
were freshly distilled prior to use. Anhydrous solvents and 
anhydrous Lewis acid catalysts were prepared as 
described.21 Organic solutions were dried using anhydrous 
MgS04 and evaporated in Biichi rotary evaporators. TLC: 
Kieselgel 60 F254 (Merck), solvent systems: CH2Cl2/MeOH, 
hexane/EtOAc, visualization: UV light, H2S04/ethanol. 
Mp: Electrothermal IA 8103 apparatus. IR spectra: Bio-
Rad FTS-60A (KBr pellets unless otherwise stated, vmJ 
c m - 1 , s, strong; m, medium; w, weak). NMR: Bruker 
Avance DRX 400 and 500 spectrometers (1H: 400.13, 
500.13 MHz; 13C: 125.76 MHz, respectively), MeOD, 
CDC13 solutions, <5 (ppm), J (Hz). Spectral patterns: s, 
singlet; d, doublet; dd, doublet of doublet; t, triplet; m, 
multiplet; br, broad; deut, deuterable. The superscripts *, # 
denote interchangeable assignments. For the 2D experi-
ments (HSQC, HMBC, NOESY) the standard Bruker 
software packages (INV4GSSW, INV4GSLRNDSW) 
were applied. LRMS: Finnigan MAT TSQ 7000, ESI 
technique. HRMS: VG ZAB SEQ high resolution mass 
spectrometer using FAB ion source. Samples were dis-
solved in glycerol, the resolution of the instrument was 
10,000. TLC/MS; TLC/HPLC: the analyte solution has been 
applied onto a 5 cm wide silica gel TLC plate as a band to 
obtain sufficient material. After developing in a solvent 
system the appropriate band was removed, the silica gel was 
suspended in MeOH (100 pL for MS, 1000 pL for HPLC), 
sonicated, centrifuged and the supernatant was used for MS 
analysis and HPLC (for HPLC 10 pL was injected). HPLC: 
SHIMADZU UV/VIS detector: SPD-10A VP, pump: LC-
10AC VP, column: LiChrospher 6.1, RP select B (5 pm). 
Eluent system: gradient: 70-90% ACN within 25 min, flow 
rate: 1 mL/min. 
5.1.1. (2Sr3S,4/J)-l-(Hydroxyimino)hex-5-ene-2,3,4-triyl 
tribenzoate (4). The unsaturated aldehyde 311 (5.00 g, 
10.92 mmol, 1 equiv) was dissolved in ethanol (100 mL) 
and distilled water (30 mL). The solution was treated with 
hydroxylamine hydrochloride (3.41 g, 41.19 mmol, 
4.5 equiv) and sodium hydrogen carbonate (3.41 g, 
49.80 mmol, 4.6 equiv). After 2 h stirring at room tempera-
ture, the ethanol was removed under reduced pressure, and 
the residue was dissolved in dichloromethane (100 mL). 
The solution was washed with water (3X50mL), dried 
(MgS04) and evaporated in vacuo. Further purification was 
accomplished by column chromatography [10%-50% (v/v) 
EtOAc in hexane] to give oxime 4 as a light yellow oil 
(5.16 g, 70%, 1:1 mixture of £ and Z isomers). Rf: 0.60; 0.53 
(£/Z isomer), (1:1, hexane/EtOAc); IR (film, i/max/cm_1): 
3426m, 3069w, 2984w, 1726s, 1601m, 1450m, 1315m, 
1260s, 1246s, 1177m, 1105s, 1094s, 1069s, 1026m, 942w, 
710s; <5h (500 MHZ, CH3OD): 5.36 (m, 2H, H-6a, H-6b), 
6.02 (m, 4H, H-2, H-3, H-4, H-5), 6.60 (m, 1H, H-L , E) 6.80 
(d, 1H, J, 2 = 5.4 Hz, H-l, Z), 7.34-7.56 (m, 9H, arom. H), 
7.96-8.04 (m, 6H, arom, H), 8.63 (s, 1H, OH). <5C (125 MHz, 
CH3OD): 68.1 (C-2, Z), 71.8 (C-2, £), 73.8 (C-3, Z), 74.5 
(C-3, £), 74.6 (C-4, £), 74.8 (C-4, Z), 120.4 (C-6, £), 121.0 
(C-6, Z), 129.6-129.7 (6 X arom. CH), 130.7 (3 X arom. Cq), 
130.8 (6 X arom. CH), 132.7 (C-5, Z), 134.6 (C-5, £), 134.7 
(3Xarom. CH), 145.9 (C-l, E) 147.0 (C-l, Z), 166.6 
( C = 0 ) , 166 .7 ( C = 0 ) , 167.1 ( C = 0 ) ; L R M S ( E S I ) : m/z 
474 (57%, [M+H] + ) , 491 (100%, [M + NH4]+), 496 (75%, 
[M + Na] + ); HRMS (FAB, glycerol): Calcd for C27H24N07 
[M + H] + m/z 474.15473, found m/z 474.15418. 
5.1.2. (2S,3S,4R)-2,3,4-Tris(benzoyIoxy)-A-(furan-2-
ylmethylene)hex-5-en-l-amine oxide (6). To a stirred 
solution of oxime 4 (0.50 g, 1.06 mmol, 1 equiv) in dioxane 
(5 mL) was added sodium cyanoborohydride (0.22 g, 
3.20 mmol, 3 equiv) in small portions, while the solution 
was carefully treated with HCl/dioxane (1.7 M, ~ 1 mL), to 
maintain the pH between 3 and 5. After completion of 
reaction (TLC), the solution was evaporated in vacuo, the 
residue was dissolved in EtOAc (50 mL), the organic layer 
was washed with aqueous sodium carbonate (40 mL), water 
(40 mL) and brine (40 mL), dried (MgS04) and evaporated 
in vacuo. The resulting hydroxylamine 5 was used without 
any further purification. 
Compound 5 was dissolved in toluene (20 mL) and treated 
with freshly distilled 2-furaldehyde (176 pL, 2.12 mmol) in 
the presence of 4 A molecular sieves. After stirring at 50 °C 
for 18 h, the solution was filtered, evaporated under reduced 
pressure and co-evaporated with ACN (3X50 mL). The 
crude residue was purified by column chromatography (10-
30% (v/v) EtOAc in hexane) to give nitrone isomers 6 as a 
pale yellow foam (0.23 g, 40%). R{: 0.17; 0.23 (£/Z isomer, 
7:3, hexane/EtOAc); IR (KBr, vmJcm~l): 3429w, 3065w, 
2980w, 1728s, 1612m, 1601w, 1450w, 1315m, 1261s, 
1240s, 1179w, 1107s, 1096s, 1069m, 1026w, 948w, 863m, 
708s; 5h (500 MHZ, CDC13): 4.31 (d, 1H, Y12 = 5.5Hz, 
H-l), 5.35 (d, 1H, y 5 « ,= 10.1 Hz H-6b, Z), 5.45 (d, 1H, 
H-6a, / j 6 a = 16.6 Hz, £), 5.95-6.07 (m, 4H, H-2, H-3, H-4, 
H-5), 6.16 (dd, 1H, /3<4<= 1-7 Hz, y4»5, = 3.4Hz, H-4'), 
6.52 (d, 1H, 73 ' .4 '=1.7Hz, H-3'), 7.26 (s, 1H, 
- 0 + N = C H ) , 7.34-7.42 (m, 9H, arom. H), 7.79 (d, 1H, 
h ' 5'= 3.4 Hz, H-5'), 7.97-8.04 (m, 6H, arom. H). <5C 
(125 MHz, CDClj): 65.3 (C-l), 69.5 (C-2), 73.0 (C-4*), 
73.5 (C-3*), 112.4 (C-3'), 116.3 (C-4'), 120.7 (C-6), 127.3 
(CH=N), 128.4 (3 X arom. CH), 128.5 (3 Xarom. CH), 
128.6 (arom. Cq), 129.7 (3Xarom. CH), 129.9 (3Xarom. 
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CH), 131.5 (C-5), 133.2 (arom. CH), 133.5 (2Xarom. CH), 
144.0 ( C - 5 ' ) , 146 .3 ( C - 2 ' ) , 165 .1 ( C = 0 ) , 165 .3 ( C = 0 ) , 
165.7 ( C = 0 ) ; LRMS (ESI): mlz 554 (100%, [M + H] + ), 
576 (20%, [M + Na] + ); HRMS (FAB, glycerol): Calcd for 
C32H28NOS [M + H] + mlz 554.18094, found mlz 554.18324. 
5.1.3. (3S,4R,5S,6S,8S)-8-(Furan-2-yl)-9-oxa-l-aza-
bicyelo[4.2.I]nonane-3,4,5-triyl tribenzoate (7b); (3S, 
4/?,SS,61?,8S)-8-(furan-2-yl)-9-oxa-l-azabicyclo-[4.2.1)-
nonane-3,4,5-triyl tribenzoate (7c) and (3S,4R,5S, 
6S,8tf)-8-(furan-2-yl)-9-oxa-l-azabicyclo[4.2.1]-nonane-
3,4,5-triyl tribenzoate (7d). General procedure. The pure 
nitrone 6 (0.40 g, 0.72 mmol) was dissolved in dry toluene 
(20 mL) in the presence of 4 A molecular sieves and the 
solution was heated at 80-100-120 °C (bath temperature) 
for 12-48 h under an argon atmosphere. The reaction 
mixture was cooled, filtered, evaporated in vacuo and co-
evaporated with ACN (3X50 mL). Chromatographic puri-
fication [0-10% (v/v) EtOAc in hexane], yielded three 
isomers (7b,7c,7d) as an oil or foam, in different isomer 
ratios depending on the reaction conditions, in 17-90% 
yield (Table 6). The ratios of the three diastereisomers were 
determined by TLC, RP-HPLC and 'H NMR (Table 6). The 
reactions were carried out under different conditions, for 
example, solvents, temperature, reflux time and with or 
without Lewis acid catalysts (see Table 5). The catalysts, 
anh. ZnCl2, anh. MgCl2 and freshly distilled B F 3 O E t 2 , 
were used in 0.1-0.2 mol equiv with respect to nitrone. R{: 
0.32 (7:3, hexane/EtOAc as a single spot; after 5 X 
development in an 8:2, hexane/EtOAc eluent it could be 
separated into three isomers). 
Compound 7b: IR (KBr, vm a x /cm~'): 3429w, 3065w, 
2961w, 1726s, 1601w, 1450w, 1315m, 1281s, 1261s, 
1179w, 1107s, 1096s, 1069m, 1026w, 708s; 5H (500 MHz, 
CDC13): 2.75 (ddd, 1H, y7a>7b= 13.1 Hz, 76,7a = 8.8# Hz, 
7 7 a 8 = 3.6*Hz, H-7a), 3.18 (ddd, 1H, 7 7 a , 7 b = 13.1 Hz, 
7 7 b 8 = 8 .5 # Hz, 7 6 7 b = 3 .8*Hz, H-7b), 3.22 (dd, 1H, 
7 2 a " 2 b =13 .8Hz , y2a 3 = 7.9 Hz, H-2a), 4.22 (dd, 1H, 
7 2 a ' 2 b = 1 3 . 8 H z , y2b 3 = 4.9 Hz, H-2b), 4.63 (dd, 1H, 
7 7 b 8 = 8.5#Hz, y 7 a 8 = 3.6*Hz, H-8), 5.02 (m, 1H, H-6), 
5.68 (dd, 1H, y 4 5 = 7.9 Hz, 75,6 = 6.0 Hz, H-5), 5.85 (m, 1H, 
H-3), 6.00 (dd, 1H, y3 4 = 9.2 Hz y4,5 = 7.9 Hz, H-4), 6.28 (d, 
1H, y3-4- = 3.2Hz, H-3'), 6.32 (dd, 1H, 73<>4 '=3.2 Hz, 
y4-51=1.9 Hz, H-4'), 7.24-7.50 (m, 10H, arom. H, H-5'), 
7.86-8.00 (m, 6H, arom. H); <5C (125 MHz, CDC13): 34.2 
(C-7), 58.7 (C-2), 65.4 (C-8), 68.8 (C-3), 73.1 (C-4, C-5), 
77.7 (C-6), 106.2 (C-3'), 110.3 (C-4'), 128.3 (3 X arom. 
CH), 128.4 (3 X arom. C), 129.6 (3 X arom. Cq, 3 X arom. 
CH), 129.7 (3 X arom. CH), 133.2 (3 X arom. CH), 142.3 
(C-5'), 154.3 (C-2'), 165.0 (Cq), 165.1 (Cq), 165.6 (Cq); 
LRMS (ESI): mlz 554 (100%, [M + H] + ), 576 (50%, 
[M + Na] + ) ; HRMS (FAB, glycerol): Calcd for C 3 2 H 2 g N0 8 
[M + H]+m/z 554.18094, found mlz 554.18213. 
Compound 7c: IR (KBr, ^ » / c m ' 1 ) : 3433w, 3063w, 
2924w, 1726s, 1601w, 1450m, 1315m, 1281s, 1271s, 
1179w, 1107s, 1069m, 1026m, 710s; <5H (500 MHz, 
CDC13): 2.83 (ddd, 1H, 7 7 a , 7 b = 13.5 Hz, y7a,8 = 11.0 Hz, 
y 6 7 a = 6 .1Hz, H-7a), 2.89 (dd, 1H, y 2 a, 2 b= 15.0 Hz, 
y 2 b 3 = 4 . 0 H z , H-2b), 3.14 (ddd, 1H, y 7 a, 7 b= 13.5 Hz, 
7 6 j b = 1 0 . 0 H z , y7b,s = 9.5 Hz, H-7b), 3.60 (dd, 1H, 
7 ^ 2 b = 1 5 . 0 H z , y2a ,3= 10.9 Hz, H-2a), 4.74 (dd, 1H, 
y 7 a , 8=11.0Hz, y7b 8 = 9.5 Hz, H-8), 4.82 (dd, 1H, y 6 7 b = 
10.0Hz, 767a = 6.1 Hz, H-6), 5.51 (d, 1H, 7 4 5 = 7.6 Hz, 
H-5), 5.96 (ddd, 1H, 7 3 4 = 10.9 Hz, 7 2 a 3 = 10.9 Hz, 7 , b 3 = 
4.0Hz, H-3), 6.21 (dd, 1H, 7 3 4 = 1 0 . 9 H z , 7 4 3 = 7.6 Hz, 
H-4), 6.44 (dd, 1H, 73<4< = 3.2 Hz, 74<5' = 2 Hz, H-4'), 6.60 
(d, 1H, 73'i4» = 3.2 Hz, H-3'), 7.19-7.54 (m, 9H, arom. H, 
IH, H-5'), 7.75-8.00 (m, 6H, arom. H); <5C (125.76 MHz 
CDC13): 38.1 (C-7), 54.7 (C-2), 60.9 (C-8), 68.1 (C-3), 79.2 
(C-5), 74.7 (C-4), 81.8 (C-6), 110.8 (C-4') 111,2 (C-3'), 
127.6 (3 X arom. CH), 127.9 (3 X arom. CH), 129.0 (3X 
arom. CH, 3 X arom. Cq), 132.5 (3 X arom. CH), 132.9 (3X 
arom. CH), 143.6 (C-5'), 147.1 (C-2'), 164.3 (CA 165 1 
(Cq), 165.7 (Cq); LRMS (ESI): mlz 554 (100%, [M + H] + ), 
576 (43%, [M + Na] + ); HRMS (FAB, glycerol): Calcd for 
C 3 2 H 2 8 N0 8 [M + H ] + mlz 554.18094, found mlz 554.18268. 
Compound 7d: IR (KBr, ^ „ / c m " " ' ) : 3067w, 2928w, 
1730s, 1601w, 1450w, 1315w, 1281s, 1260s, 1179w, 
1109m, 1096m, 1070m, 1026w, 710m; <5H (500 MHz' 
CDCI3): 2.67 (ddd, 1H, 7 7 a 7 b = 13.2 Hz, 7 6 7 a = 8.7Hz! 
y7a,8 = 7.2 Hz, H-7a), 2.86 (ddd, 1H, 7 7 a 7 b = 13.2 Hz, 77b 8 = 
II .2 Hz, 76.7b = 6.2 Hz, H-7b), 3.02 (dd, 1H, 7 2 a 2 b = 12.5 Hz, 
72 a ,3= 10.3 Hz, H-2a), 3.53 (dd, 1H, 7 2 a 2 b = 12.5 Hz, 7 2 b 3 = 
4.0Hz, H-2b), 4.71 (dd, 1H, 77a>8 = 7.2Hz, 7 7 b 8 = 11.2Hz, 
H-8), 4.96 (ddd, 1H, 76,7a =8 .7 Hz, 7 6 7 b = 6.2Hz, J56= 
5.8 Hz, H-6), 5.89 (ddd, 1H, 7 2 a 3 = 1 0 . 3 H z , 7 3 4 = 1 0 . 1 Hz, 
Jib.3=•4.0 Hz, H-3), 5.69 (dd, 1H, 74 s = 8.7 Hz, 7S 6 = 5 . 8 Hz, 
H-5), 5.98 (dd, 1H, 73>4=10.1 Hz, 74,5 = 8.7 Hz, H-4), 6.42 
(dd, 1H, 73'>4' = 3.1 HZ, 74 '5>=1.9HZ, H-4'), 6.51 (d, 1H, 
73',4' = 3.1 HZ, H-3'), 7.20-7.25 (m, 3H, arom. H), 7.39-7.41 
(m, 3H, arom. H), 7.49-7.52 (m, 4H, arom. H, H-5'), 7.78-
7.82 (m, 3H, arom. H), 7.97-7.99 (m, 3H, arom. H); 6C 
(125 MHz, CDC13): 31.2 (C-7), 52.2 (C-2), 64.1 (C-8), 66.8 
(C-3), 73.2 (C-5), 74.6 (C-4), 77.6 (C-6), 111.1 (C-3'), 110.7 
(C-4'), 128.1, 128.2 (3Xarom. CH), 128.5 (3Xarom. Cq,) 
129.6 (3 Xarom. CH) 129.8 (3 X arom. CH), 133.0 (3 X arom 
CH), 133.4 (3 X arom. CH), 143.4 (C-5'), 148.1 (C-2'), 165.0 
(Cq), 165.4 (Cq), 165.9 (Cq); LRMS (ESI): mlz 554 (100%, 
[M + H] + ) , 576 (56%, [ M + N a ) + ) ; HRMS (FAB, glycerol): 
Calcd for C 3 2H 2 8N0 8 [ M + H ] + m / z 554.18094, found mlz 
554.18379. 
NOESY data: Table 4. 
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Abstract—Epimeric pyrrolidinyl glycines, a sort of conformationally constrained a,|3-diaminoacids, were stereoselectively prepared 
Using complementary approaches based on nitrone chemistry. Nucleophilic additions to pyrrolidinyl nitrones and 1,3-dipolar cyclo-
additions of L-serine derived nitrones to form the corresponding hydroxylamines and isoxazolidines, respectively, provided key 
intermediates for the synthesis of the target compounds. Whereas the nucleophilic addition route afforded the syn adduct, the 
1,3-dipolar cycloaddition approach furnished the precursor for the preparation of the corresponding anti compound. 
© 2006 Elsevier Ltd. All rights reserved. 
ot.P-Diaminoacids 1 are interesting targets because of 
their utility as synthetic intermediates as well as their 
Presence in several biologically active compounds.1 In 
addition, much attention was focused during the last 
years on the preparation of conformationally con-
strained amino acids.2 A recent surge of activity into 
the synthetic chemistry of hetaryl glycines, in particular, 
tetrahydrofuranyl derivatives is also indicative of the 
importance of this area.3 
Pyrrolidinyl glycines 2 can be considered as conforma-
tionally restricted a,|3-diamino acids whose preparation 
is still scarcely considered. To the best of our knowledge, 
such compounds have only been synthesized in part i-
cular cases. Compounds 3 have been used as synthetic 
intermediates for the preparation of bicyclic piperazine 
2-carboxylic acids4 that have been further utilized in 
asymmetric synthesis as either catalysts or building 
blocks.5 Bicyclic pyrrolidinyl glycines 4 have also been 
employed as intermediates in the synthesis of models 
for the azinomycin6 and ficellomycin7 antibiotics 
(Fig. 1). 
* Corresponding authors. Tel./fax: +34 976 762075 (P.M.); e-mail: 
pmerino@unizar.es 
As a part of our continuing research program on the syn-
thetic potential of nitrones, and in the preparat ion of 
non-proteinogenic aminoacids,8 including ot,p-diamino 
acids,9 we now report on two new complementary routes 
leading to epimers at the P-stereogenic center of pyrroli-
dinyl glycines. 
The synthetic approaches are based on nitrone chemis-
try and they make use of the two different and well-
known reactivities of the nitrone functionality in 1,3-
dipolar cycloadditions and nucleophilic additions.1 0 
NHBoc NHCbz 
3 4 
Figure X. 
0040-4039/$ - see front matter © 2006 Elsevier Ltd. All rights reserved, 
doi: 10.1016/j.tetlet.2006.05.114 
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Scheme 1. Reagents and conditions: (i) A c 2 0 , Py, rt; (ii) BU4NF, THF, rt; (iii) R U C 1 3 , NaIO„, CH 3 CN-CC1 4 -H 2 0 ( 3 : 2 : 2 ) , rt; (iv) CH 2 N 2 , E t 2 0 , rt; 
(v) H2 , 100 atm, Pd(OH)2-C, Boc 2 0 , rt. 
Our first approach started from the completely stereo-
selective addition of lithium trimethylsilyl acetylide to 
the pyrrolidinyl nitrone 5 (Scheme 1). Only one isomer 
could be detected in the reaction mixture and compound 
6 (Mp +5 (c 0.21, CHC13)) was obtained in 93% chem-
ical yield." The stereochemical course of the reaction 
can be explained on the basis of our previously reported 
model for nucleophilic additions of Grignard reagents to 
pyrrolidinyl nitrones.12 The absolute configuration of 6 
was unambiguously assigned following our previously 
reported empirical rule based on NMR measurements.13 
After protection of the A-hydroxyamino group as an 
acetyl derivative, compound 7 (100%; [a]D - 2 7 (c 0.41, 
CHC13)) was obtained. Unfortunately, all attempts of 
oxidizing the ethynyl group to a carboxylic acid either 
with R u 0 2 or RUC13 in the presence of an excess of 
sodium periodate as a reoxidant, failed; only decomposi-
tion products were recovered from the reaction 
mixtures. A similar behavior had already been observed 
in our laboratory.14 Thus the silyl groups in 6 were 
cleaved with TBAF in THF and after acetylation of 
the resulting crude product, compound 8 (89%; 
[a]D - 3 7 (c 0.38, CHC13)) was obtained. 
In this case, unmasking of the carboxyl moiety was car-
ried out by oxidation of the triple bond with the system 
RuCl 3 -NaI0 4 in good yield, thus demonstrating that 
the replacement of the O-silyl protecting group by the 
acetyl one and/or removal of the C-silyl group is crucial 
for the success of the oxidation. After esterification of 
the crude carboxylic acid with freshly prepared diazo-
methane, the TV-(acetoxy) pyrrolidinyl glycine 9 (73%; 
[a]D - 3 9 (c 0.25, CHC13)) was obtained after purifica-
tion by radial chromatography. Hydrogenation under 
pressure (100 atm) in the presence of the Pearlman's cat-
alyst and B O C 2 0 afforded the protected pyrrolidinyl gly-
cine 10 in 57.4% overall yield (six steps from nitrone 
5).15 
Our second approach was based on the hitherto un-
known 1,3-dipolar cycloaddition between the L-serine 
derived nitrone 11 and methyl acrylate (Scheme 2). 
The reaction was conducted without solvent at 90 °C 
in a sealed tube for 5 h. The N M R analysis of the crude 
mixture revealed the presence of four isomers in 35:7:7:1 
ratio, which was further confirmed by HPLC (XTerra 
C18, 5 pm, MeOH-H 2 0 , 3:2). After separation of the 
adducts by OPLC (OPLC-50, 0.2 mm HTSorb™ 5 pm 
silica gel layer, hexane/EtOAc 8:2, 50 bar, 500 pL/min) 
the major adduct 12a was obtained in 56% isolated 
yield.'6 The stereochemical assignment of 12a-d was 
determined by careful NMR analysis utilizing homonu-
clear decoupling, multiple-difference NOE and 2D 
experiments including COSY, ROESY, and HMQC. 
Moreover, the observed stereochemical induction is in 
agreement with previous observations for a-alkoxy and 
a-amino nitrones for which, in all cases, the diastereo-
facial induction showed to be anti with respect to the 
heteroatom in a position to the nitrone moiety.17 Tenta-
tively, we suggest that this stereochemical outcome is in 
agreement with the transition state model A illustrated 
in Figure 2 corresponding to an endo approach of the 
dipolarophile to the Re face of the nitrone. 
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Scheme 2. Cycloaddition between 11 and methyl acrylate. 
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Figure 2. Proposed model for the 1,3-dipolar cycloaddition between 11 
and methyl acrylate. 
Catalytic hydrogénation of 12a using Pearlman's cata-
lyst provided pyrrolidinone 13 ([a]D - 3 3 (c 0.21, 
CHC13); mp 164-166 °C) in 95% yield (Scheme 3). 
Compound 13 was treated with ierf-butyldiphenyl silyl 
chloride and Boc 2 0 to afford the protected pyrrolidin-
2-one 14 ([a]D +34 (c 0.22, CHCI3)). However, acidic 
hydrolysis of the oxazolidine moiety to liberate the pri-
mary hydroxyl group as a previous step for the oxida-
tion reaction afforded a 3:2 mixture of the expected 
compound 15a ( f a ] D +25 (c 0.17, CHC13)) and 15b 
([a]D - 6 (c 0.30, CHCI3)), the latter coming f rom an 
unexpected silyl migration. 
In order to avoid the silyl migration, we then decided to 
change the protecting group of the hydroxyl group. 
After benzoylation and N-protection of 13, compound 
16 (80%, [a]D +45 (c 0.25, CHC13)) was obtained as 
the immediate precursor of the target compound 
(Scheme 4). Treatment of 16 with catalytic p -TsOH in 
methanol gave rise to the free primary alcohol 17 
(80%, [afo +20 (c 0.27, CHC13)) which was subsequently 
Boc 
N 
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(95%) 
V - N H 
H O ^ V ^ o 
loc / 
(66%) 
B  
i i , h i 
13 
IV 
O, Boc 
- N 
(80%) 'BuPh2SiO N ^ - 0 
14 Bóc IOC I 
O Boc 
• / 
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NHBoc Boc 
15a 
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3 : 2 
OSiPh2'Bu 
ÑHBoc 
15b 
Scheme 3. Reagents and conditions: (i) H2 , Pd(OH)2-C, 100 atm, rt; 
(ii) 'BuPh2SiCl, imidazole, D M F , 70 °C; (iii) Boc 2 0 , Et3N, D M A P , 
CH2C12; (iv) p-TsOH, MeOH, 45 °C, 6 h. 
1,11 
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iv, v O. Boc 
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BzO' O H 
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NHBoc 
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Scheme 4. Reagents and conditions: (i) PhCOCl, Py, C H 2 C l 2 , 0 °C; (ii) 
BOC20, Et3N, D M A P , CH2Cl2; (iii) p-TsOH, MeOH, 45 °C, 6 h ; (iv) 
TEMPO, [bis(acetoxy)iodo]benzene, M e C N - H 2 0 ; (v) CH 2 N 2 , E t 2 0 , 
rt. 
oxidized with the system TEMPO-BAIB 1 8 to afford the 
crude carboxylic acid. This compound was isolated and 
fully characterized19 as the corresponding methyl ester 
18 which was obtained by treatment of the acid with 
an ethereal solution of freshly prepared diazomethane. 
Compound 18 was obtained in 17% overall yield (seven 
steps from nitrone 11). 
We also attempted the reduction of the lactam moiety in 
compound 18 to obtain the corresponding saturated 
pyrrolidine, following the Garcia-Ruano's procedure.2 0 
Unfortunately, the reduction failed and only the starting 
compound was obtained.2 1 
In conclusion, two complementary routes leading to syn-
and awfi-pyrrolidinyl glycines via a nucleophilic addit ion 
to nitrone 5 and a cycloaddition reaction of 11 with 
methyl acrylate, respectively, have been achieved. In 
the first approach, an ethynyl group has been used as 
a synthetic equivalent of the carboxyl unit. For the sec-
ond approach, the synthetic equivalence between the 
oxazolidine ring and the glycine unit has been utilized. 
Unusual conformationally constrained a,P-diamino-
acids containing both a saturated ring of pyrrolidine and 
a pyrrolidin-2-one ring have been successfully prepared 
in this work. The preparation of other pyrrolidinyl gly-
cines of interest through these methods, as well as chem-
ical modifications of the prepared compounds are now 
underway in our laboratories. 
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studying this possibility and it will be reported in due 
course. 
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Single diastereomers of polyhydroxylated 9-oxa-l-azabicyclo[4.2.1]nonanes from intramolecular 
1,3-dipolar cycloaddition of to-unsaturated nitrones 
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Kovács13* 
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Sciences, William H. Perkin Building, Heriot-Watt University, Riccarton, Edinburgh, EH14 4AS,UK 
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Abstract. 8-Benzyloxymethyl-3,4,5-tribenzoyloxy-9-oxa-l-azabicyclo[4.2.1]nonane has been prepared 
as a single diastereoisomer 8 from an intramolecular 1,3-dipolar cycloaddition involving 2-
(benzyloxy)acetaldehyde and co-unsaturated hydroxylamine 7 derived from methyl a-D-
glucopyranoside. The analogous 8-methoxycarbonyl 9-oxa-l-azabicyclo[4.2.1]nonane was afforded in a 
similar manner, from methyl D-galactopyranoside and methyl glyoxylate, as a 3:1 mixture of 
diastereoisomers 15 and 16. When conducted in achiral ionic liquid 17 this ratio increased to 8:1 and, in 
chiral ionic liquid 18, compound 15 was formed exclusively. 
D-gluco, D-galacto 8 (R = CH2OBn) 15,16 (R = C02Me) 
SI-1 
Glycosidases are intimately involved in a plethora of metabolic pathways and the development of 
glycosidase inhibitors presents an enormous challenge for the treatment of associated disorders, e.g. 
diabetes, Gaucher's disease, cancer and viral infections including AIDS.'"1 Recently, highly oxygenated 
chiral heterocycles containing nitrogen (also referred to as azasugars, iminosugars or iminocyclitols) 
have emerged as potential glycosidase inhibitors worthy of further investigation.6'' 
Our interest in this field stems from our previous synthetic efforts to prepare chiral azetidines. En 
route to these compounds, diastereomeric mixtures of hydroxylated chiral 9-oxa-l-
azabicyclo[4.2.1]nonanes were produced through an intramolecular 1,3-dipolar cycloaddition involving 
©-unsaturated nitrones derived from D-glucose and 2-furaldehyde." This nitrone-alkene cycloaddition is 
a well-known powerful tool which has successfully been employed in the literature to construct a 
variety of isoxazolidines, 1,3-aminoalcohols and derivatives9,10 usually starting from carbohydrate 
precursors,11,12 Recently, a ring-contracted dihydroxylated 8-oxa-l-azabicyclo[3.2.1]octane and its ring-
opened azepane derivative have been found to be effective glycosidase inhibitors.13 
As highlighted above, due to the increasing biological interest in this class of compounds, we have 
decided to explore the scope of this intramolecular 1,3-dipolar cycloaddition. Therefore, we have 
investigated the utility of other aldehydes and sugars, namely D-glucose and D-galactose, and our 
findings are presented herein. 
Thus, we first embarked on investigation of the iodination of methyl a-D-glucopyranoside 1 using the 
conditions described by Vasella and Garegg (Scheme 1). After extensive experimentation, we have 
found that iodo compound 2 can only be obtained reproducibly in good yields (60%) on a large scale 
when using a modified procedure which requires careful consideration of reaction conditions (e.g. 
reagent addition times, temperature, strirring) and combination of different purification procedures. 
Subsequent benzoylation of compound 218"20 successfully afforded benzoate 3.21"23 The latter halo 
derivative 3 was then subjected to the Boord-Vasella reaction (which involved treatment with 
activated zinc in various solvents, under sonication). 
2 
HO-
HO' )• "OMe '"OMe 
Surprisingly, despite the fact that there are numerous 
publications in the literature dealing with this 
•"OMe 
BzO BzO 
BzO OBz 
[— 4 X = CHO 
5X = CH=NOH 
d U- 7X = CH2NHOH 
•"OMe 
O 
BnOH2C- M -T-OBz 
v . ^ V ^ - O B z 
^ OBz 
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7s) OBz 
reaction, 14-16,22,23,29,30 an experimentally simple and 
OBz 
SCHEME 1. Reagents and conditions: (a) 
Ph3P, I2, imidazole, PhMe, 70-110 °C, 3 h, 
60%; (b) BzCl, py, CH2C12, 0-25 °C, 16 h, 
85%; (c) 1. Zn, various solvents, 
sonication, 40-60 °C, 4-5 h, 2. 
NH2OHHCl, aq. Na2C03, CH2C12, 5: 0-
65%, 6: 27-85%; (d) NaBH3CN, dioxane, 
MeOH, pH=1.4-1.5, rt, 45 min; (e) 
BnOCH2CHO, PhMe, 4A mol. sieves, 110 
°C, 20 h, 28% overall 
reliable method suitable for the production of co-
unsaturated aldehyde 4 could not easily be established. 
We reported previously that, although many different 
reaction conditions worked well on small scale, 
increasing the scale of transformation was typically 
accompanied with a considerable decrease in product 
yield.8 We also noted, in the present case, that the 
nature of solvent had a dramatic effect both on yield 
and chemoselectivity of the reaction. That is to say, 
aldehyde 4 (isolated as a stable oxime 5,8 1:1 E/Z 
mixture) was consistently afforded in 55-65% yield 
along with the undesired side product 631'32 (27-32%) 
when solutions of 3 in THF-aq. MeOH or THF or 
MeCN-aq. MeOH mixtures were treated with CeCl3-
activated zinc. However, in neat dioxane, the yield of 
compound 5 was drastically reduced (12%) while the 
yield of the concurrent 6-deoxy derivative 6 
substantially increased (75%) and in other neat solvents 
(DMF, MeCN, acetone, di-i-propyl ether) compound 6 
was produced exclusively (85%). Fiirstner et al. have 
likewise noted that less reactive halo derivatives (e.g. 
6-bromo-6-deoxysugars) are prone to reduction. 
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Finally, oxime 5 was successfully transformed into cycloadduct 8 in a one-pot reaction involving first 
reduction to the corresponding hydroxylamine 7 using NaBHjCN at controlled pH (1.4-1.5, in organic 
phase) followed by condensation of the resulting unstable product with a freshly prepared solution of 2-
(benzyloxy)acetaldehydC;; in dry toluene (5 —» 8: 28% overall). Cycloadduct 8 was the only isolable 
compound from the reaction mixture and the purified substance was a single spot/peak according to 
TLC, OPLC and HPLC. The gross structure and the configurations at all the newly formed stereocenters 
were assigned using ID and 2D NMR measurements (HSQC, HMBC, NOESY) and based on the 
known configuration of pre-existing stereocenters (35, 4R, 55) which had arisen from the former 
carbohydrate moiety. In the NOESY spectrum the following protons were found to reside on the top-
face (relative to the 9-oxa-l-azabicyclo[4.2.1]nonane skeleton as depicted in Scheme 1): H-3/H-2b; H-
5/H-6; H-6/H-7b while protons H-7a/H-8/H-4; H-8/H-2a/H-4 were on the bottom. This clearly 
demonstrates that proton H-6 and the benzyloxymethyl substituent at position 8 are located on the same 
side (P~) and their absolute configuration is (65, 85). Therefore, the configurational preference for this 
intramolecular 1,3-dipolar cycloaddition was found to parallel that reported previously for the analogous 
reaction employing a nitrone derived from 2-furaldehyde and D-glucose.8 It is remarkable, however, that 
changing a substituent from 2-furyl to benzyloxymethyl at position 8 affects drastically the 
diastereoselectivity of this 1,3-dipolar cycloaddition: with 2-furyl substituent three difficult-to-separate 
diastereomers were obtained8 whereas the benzyloxymethyl substituent directed the reaction to the 
exclusive formation of single diastereomer 8. The formation of the alternative regioisomer (an 8-oxa-l-
azabicyclo[4.2,l]nonane with a bridgehead methyne group) was not observed. It is generally assumed 
that in such cycloadditions the new C-C bond is more developed in the transition state than the C-0 
bond (cf. Scheme 1, TS1) and hence both for steric and electronic reasons, the C-C bond is preferably 
formed at the less substituted alkene position,8,13'34,35 although the effects of substituents and ring-sizes 
on the regioselectivity show significant variation.34'36,37 
In order to expand the repertoire for this reaction we have investigated the corresponding 
intramolecular 1,3-dipolar cycloaddition for a nitrone prepared from methyl D-galactopyranoside. In this 
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SCHEME 2. Reagents and conditions: (a) BzCl, 
py, CH2C12, 0-25 °C, 4 h, 90%; (b) NBS, BaC03, 
CHC13, C1CH2CH2C1, 65 °C, 3 h, 70%; (c) 1. Zn, 
cat. CeCl3, NH4CI, MeOH, THF, sonication, 40 
°C, 3 h, 2. NH2OH.HCl, aq. K2C03, Et20, it, 16 
h, 72% overall; (d) NaBHjCN, MeOH, pH=1.4-
1.5, it, 1 h; (e) Me02CCH0, 4A mol. sieves, 110 
°C, 20 h, PhMe or 17 or 18, 64-79% 
case, functionalization required a slightly different 
approach as direct halogenation of methyl D-
galactopyranoside at position 6 proved to be 
problematic due to steric hindrance exerted by the 
axial hydroxyl group at position 4. Thus, compound 
938 (Scheme 2), which was readily available from 
methyl D-galactopyranoside, was utilized instead. 
OQ 
Following benzoylation, 10 was subjected to 
Hanessian-type oxidative ring opening40 using NBS to 
afford the 6-bromo-6-deoxy derivative 11, 
characterized as two separate epimers. The Boord-
Vasella ring-opening of 11 gave aldehyde 12 (isolated 
as the stable oxime 13, 2:1 E/Z mixture) in 72% yield. 
Occasionally, by-products from this reaction (e.g. the 
corresponding 6-deoxy pyranose) were also observed 
but, in most cases, this proved to be negligible. Oxime 
13 was successfully reduced under identical conditions 
to those used above for the D-gluco derivative 
(NaBH3CN, MeOH, pH = 1.4-1.5) and the resulting 
hydroxylamine 14 was condensed without any further 
purification with a freshly prepared solution of 
methyl glyoxylate41 in dry toluene. For this 
cycloaddition the intermediate nitrone yielded two 
cycloadducts, 15 and 16, in a 3 : 1 ratio (13 —• 15 + 
16: 64%). Configurational assignment for all the 
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newly formed stereocenters was again performed employing 2D NMR techniques. NOESY data 
revealed the spatial proximity of protons H-2b/H-3; H-6/H-7b/H-8 (top-face) and H-2a/H-4/H-5/H-7a 
(bottom-face) for 15 and that of protons H-2b/H-3; H-3/H-7b (top-face) and H-2a/H-4; H-4/H-5/H-6; H-
5/H-6/H-7a; H-7a/H-8 (bottom-face) for 16, respectively. This data suggests that the configuration of 
newly formed stereocenters is (65, 8R) for 15 and (6R, 85) for 16. Steric hindrance between substituents 
at C-5 and C-8 in 16 (and in the corresponding transition state TS3, Scheme 2) probably accounts for 
the sub-ordinate formation of this compound compared to 15. 
It has been reported that 1,3-dipolar cycloadditions are accelerated when performed in certain ionic 
liquids.4" Thus, in an attempt to optimize the above reaction, condensation of hydroxylamine 14 with 
freshly prepared methyl glyoxylate has also been carried out in the ionic liquid l-n-butyl-3-methyl-lH-
imidazol-3-ium hexafluorophosphate 17. Surprisingly, this reaction exhibited improved 
diastereoselectivity with 15 and 16 being isolated in a 8 : 1 ratio (13 —• 15 + 16: 72%). This unexpected 
finding prompted us to examine the use of the chiral ionic liquid (5)-3-ethyl-l-(l-hydroxypropan-2-yl)-
lii-irnidazol-3-ium hexafluorophosphate 18, prepared in a few steps from L-alanine,43 in this 
intramolecular 1,3-dipolar cycloaddition. Thus, when the above cycloaddition was repeated in 18 as a 
solvent, cycloadduct 15 was unexpectedly obtained as the sole product of the reaction (79% yield). 
Since their discovery, ionic liquids have gained much popularity owing to their unusual properties and 
interest to replace traditional solvents with these new substances is forever increasing.44'45 However, 
although the application of ionic liquids in organic chemistry is rapidly expanding, there are currently 
only a few examples in the literature reporting the use of chiral ionic liquids in asymmetric reactions 
and the best asymmetric induction obtained so far was 44% ee,46'47 One can expect a significant transfer 
of chirality in these solvents due to their high degree of organization. It has been reported that most of 
ionic liquids possess a polymeric structure and are highly ordered H-bonded liquids (three-dimensional 
¿A 
networks of anions and cations linked together by hydrogen bonds). In addition, it was recently shown 
that hydrogen bonding is involved in controlling the enio-selectivity of Diels-Alder reactions 
performed in achiral ionic liquids Thus, our unprecedented observation that a chiral ionic liquid can 
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shift an asymmetric intramolecular 1,3-dipolar cycloaddition to the exclusive formation of a single 
diastereomer is therefore a pivotal finding. 
In conclusion, 9-oxa-l-azabicyclo[4.2.1]nonanes 8,15 and 16 have been successfully prepared in four 
steps starting either from methyl a-D-glucopyranoside or methyl D-galactopyranoside, respectively, in 
overall yields of 9-36%. The key step in their synthesis involved an intramolecular 1,3-dipolar 
cycloaddition of (»-unsaturated nitrones. Upon optimizing this reaction we have discovered that use of 
the chiral ionic liquid 18 furnished cycloadduct 15 as a single diastereomer in high yield. It is clear from 
the above study that subtle changes in nature of substituent and/or configuration of the starting nitrones 
or solvent have dramatic effect on diastereoselectivity of this asymmetric intramolecular 1,3-dipolar 
cycloaddition. The availability of the above cycloadducts in pure diastereomeric form opens up new 
avenues in the study of polyhydroxylated 9-oxa-l-azabicyclo[4.2.1]nonanes and further investigations 
to exploit this approach in multistep reactions are in progress and will be reported in due course. 
Experimental Section 
(3S,4I2,55,6S,8S)-8-(Benzyloxymethyl)-9-oxa-l-azabicyclo[4.2.1]nonane-3,4,5-triyl tribenzoate (8). 
To a stirred solution of oxime 5 (3.440 g, 7.27 mmol) in dioxane (300 mL) and MeOH (300 mL) was 
added NaBH3CN (2.740 g, 43.60 mmol, 6 equiv.) while the solution was carefully treated with 
HCl/dioxane (1.7 M, -30 mL) to maintain the pH between 1.4-1.5 using a combined pH glass electrode 
for organic solutions. After approximately 45 min, when the reduction stopped (the pH of the reaction 
mixture did not alter further), the solution was evaporated in vacuo, co-evaporated with MeCN (100 
mL), the residue was dissolved in a mixture of EtOAc (400 mL) and satd. aq. Na2C03 solution (300 
mL), the organic phase was washed with additional Na2C03 solution (300 mL), water (300 mL) and 
brine (300 mL), dried (MgS04) and evaporated in vacuo. If the reaction solution still contains some 
starting material 5 (TLC), subsequent NaBH3CN (2.740 g, 43.60 mmol, 6 equiv.) has to be added and 
the pH must be maintained for a repeated 30 min period. The unstable hydroxylamine 7 was used 
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immediately without any further purification to avoid its decomposition. Rf: 0.60, hexanes : EtOAc 1 : 
1; TLC-MS (m/z): 476 (100%, [M+H]+), 498 (12, [M+Na]+). The above hydroxylamine 7 was dissolved 
in dry toluene (250 mL) and treated with freshly prepared 2-(benzyloxy)acetaldehyde (2 equiv.) in the 
presence of 4 A molecular sieves and a Dean-Stark water trap. After stirring at 110 °C for 20 h, the 
solution was filtered, evaporated in vacuo and co-evaporated with MeCN (3 x 50 mL). The residue was 
purified by silica gel column chromatography [eluent: 0-5% (v/v) Et 2 0 in CH2C12] to give the title 
cycloaddition product 8 as a pale yellow oil (1.22 g, 28% overall yield). Rf: 0.33, CH2C12 : Et20 95 : 5. 
[a]D: -26 (c=0.5, MeOH). IR (CaF2, thin film): 990 (w), 1026 (m), 1069 (m), 1096 (s), 1177 (w), 1261 
(s), 1278 (s), 1315 (m), 1451 (m), 1493 (w), 1584 (w), 1601 (w), 1724 (s), 2859 (w), 2942 (w), 3030 
(w), 3057 (w) cm"1. !H NMR (500 MHz, CDCL, 8, ppm, superscripts * and # denote interchangeable 
assignments) 2.25 (1H, ddd, J6;7b# = 8.7 Hz, 7 7 a , 7 b = 13.5 Hz, 7 7 b , g # = 4.6 Hz, H-7b); 2.96 (1H, ddd, 7 W a * 
= 2.8 Hz, # 7 a J b = 13.5 Hz, 7 7 a , g . = 8.6 Hz, H-7a); 3.14 (1H, dd, 72a,2b = 14.1 Hz, 7 2 a 3 = 7.7 Hz, H-2a); 
3.41 (1H, dd, 7 s , r a = 6.4 Hz, JlxVb = 9.4 Hz, H-l'a); 3.60 (1H, dd, 7 g , I b = 7.3 Hz, 7 r a , r b = 9.4 Hz, H-l'b); 
3.75 (1H, m, H-8); 4.24 (1H, dd, 7 2 a , 2 b = 14.1 Hz, 72 b ,3 = 5.5 Hz, H-2b); 4.57 (1H, d, = 11.9 Hz, 
H-2'a); 4.66 (1H, d, J2%rb =11.9 Hz, H-2'b); 4.86 (1H, ddd, 75>6 = 5.8 Hz, J6Jb# = 8.7 Hz, 7 6 , 7 a , = 2.8 Hz, 
H - 6 ) ; 5 . 6 6 ( 1 H , d d , 7 4 , 5 = 8 . 1 H z , 75<6 = 5 . 8 H z , H - 5 ) ; 5 . 8 4 ( 1 H , d d d , 7 2 a , 3 = 7 . 7 H z , 72b>3 = 5 . 5 H z , 73>4 = 
9.4 Hz, H-3); 5.99 (1H, dd, 73,4 = 9.4 Hz, 74.5 = 8.1 Hz, H-4); 7.37 (14H, m, arom.); 7.90 (6H, m, arom.), 
13C NMR (126 MHz, CDC13, 8, ppm) 32.8 (C-7); 59.1 (C-2); 67.6 (C-8); 69.1 (C-3); 72.6 (C-4); 73.1 
(C-T); 73.2 (C-5); 73.4 (C-2'); 77.1 (C-6); 127.7-128.3 (arom.); 129.0 (arom. Cq); 129.1 (arom. Cq); 
133.0 (arom.); 133.1 (arom.); 133.2 (arom.);138.0 (arom. Cq); 165.1 (CO); 165.1 (CO); 165.5 (CO). 
NOESY (connected protons, relative to the 9-oxa-l-azabicyclo[4.2.1]nonane skeleton), top-face: H-3/H-
2b; H-5/H-6; H-6/H-7b; bottom-face: H-7a/H-8/H-4; H-8/H-2a7H-4. LRMS (m/z): 608 (100%, [M+H]+), 
630 (25, [M+Na]+). HRMS (FAB, glycerol): calcd. for C36H34NOg+ [M+H]+ m/z 608.22789, found m/z 
608.2310. Anal, calcd. for C3 6H3 3N08 (607.649) C, 71.16; H, 5.47; N, 2.31; found C, 71.03; H, 5.59; N, 
2.48%. 
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General procedures 
Abbreviations: equiv. (equivalent), LRMS (low resolution mass spectrometry); OPLC 
(overpressurised layer chromatography). 
(S)-3-Ethyl-1 -(1 -hydroxypropan-2-yl)-1 H-imidazol-3-ium hexafluorophosphate 18 was 
prepared as described.1 Hexanes refer to a mixture of hexanes containing min. 55 % n-
hexane. Anhydrous solvents were prepared as described.2 Organic solutions were dried 
using anhydrous MgS04 and evaporated in rotary evaporators. TLC: Kieselgel 60 F254, 
visualization: UV light, iodine and/or charring with H2S04/ethanol. Optical rotation: 589 nm, 
quartz cell (100 mm), 25 °C. pH-measurement: microprocessor pH meter combined with 
pH glass electrode for organic solutions. IR spectra: CaF2, vmax/cnr1, s, strong; m, medium; 
w, weak; br, broad. NMR: 400.13 MHz and 500.13 MHz (1H); 125.76 MHz (13C), 
respectively, CDC!3 and C6D6 solutions, 8 (ppm), J (Hz). The superscripts *, # denote 
interchangeable assignments. For the 2D experiments (HSQC, HMBC, NOESY) the 
standard software packages (INV4GSSW, INV4GSLRNDSW) were applied. LRMS: ESI 
technique. HRMS: high resolution sector instrument using FAB ion source. Samples were 
dissolved in glycerol, the resolution of the instrument was 10,000. TLC-MS: the analyte 
solution has been applied onto a 5 cm wide silica gel TLC plate as a band to obtain 
sufficient material. After developing in a solvent system the appropriate band was removed, 
the silica gel was suspended in MeOH (100 pL), sonicated, centrifuged and the 
supernatant was used for MS analysis. OPLC: OPLC-50 (Bionisis, France), 0.2 mm thick 
HTSorb™ 5 jim silica gel layers (OPLC-Nit Ltd., Hungary), hexane/EtOAc solvent mixtures, 
50 bar, eluent flow: 500,uL/min. HPLC: UV/VIS detector, column: LiChrospher 6.1, RP 
select B (5 pm). Eluent system: gradient: 70-90% MeCN within 25 min, flow rate: 1 mL/min. 
Activation of zinc: zinc powder (2.65 g, 40.60 mmol) was subsequently washed with 1 M 
HCI (3 x 50 mL), water (50 mL), ethanol (50 mL) and EtaO (2 x 50 mL). Sonication: in an 
ultrasonic bath (37 kHz, 275 W). 
2-(Benzyloxy)acetaidehyde was freshly prepared using the procedure developed by 
Shiao efa/.3 and modified as follows. (±)-3-Benzyloxy-1,2-propanediol (3.32 g, 18.20 mmol) 
was dissolved in CH2CI2 (120 mL) and treated with sodium metaperiodate (9.73 g, 45.5 
mmol, 5 equiv.) in water (240 mL). This solution was stirred for overnight at rt, the phases 
were then separated, the organic layer was dried (MgSOJ, evaporated and the resulting 
oily 2-(benzyloxy)acetaldehyde was used without any further purification for the 
cycloaddition reactions. 
SI-2 
Methyl 6-deoxy-6-iodo-a-D-glucopyranoside (2)4 5 
"'OCH3 "OCH3 
Ph3P, l2, imidazole 
toluene, 70 -110 °C, 3 h 
60% 
A three-necked, 1 L flask was equipped with a condenser, a mechanical shaker and 
a stopper. The solution of methyl a-D-glucopyranoside (10.00 g, 51.50 mmol) in toluene 
(300 mL) was agitated mechanically at room temperature while triphenylphosphine (20.24 
g, 77.20 mmol, 1.50 equiv.) and imidazole (10.51 g, 154.92 mmol, 3.00 equlv.) were added 
portionwise. The mixture was heated to reflux then, after 1 h, cooled to 70 °C. Iodine 
(18.30 g, 72.10 mmol, 1.40 equiv.) was added portionwise under vigorous shaking and the 
initially brown mixture was vigorously agitated at 70 °C until the brown colour of iodine 
disappeared and then the mixture was heated at reflux for 3 h. The mixture was cooled in 
an ice-bath and extracted with water (5 x 200 mL), the aq. phase was backwashed with 
toluene (100 mL). The combined organic phases were dried (MgS04), evaporated and 
coevaporated with acetonitrile. The crude product (containing four spots according to TLC 
in toluene : /-PrOH 7 : 3, detection: UV, iodine vapor, and charring) was dissolved in hot 
etanol (100 mL) and hot EtOAc (500 mL) was added. The resulting precipitate (imidazolium 
iodide) was removed by filtration and the filtrate was concentrated and subjected to column 
chromatography (adsorbent: 250 g silica gel, eluent: toluene : /-PrOH 9 : 1 ) . The product 
was obtained as a semisolid which was then crystallized from a toluene-/-PrOH mixture. 
9.396 g (60 %), mp. 145.8-146.2 °C (lit.6 value: 146-147 °C), R,: 0.30, toluene : /-PrOH 7 
: 3. The 1H and 13C NMR spectra of the above product were in full agreement with the 
published ones.5 
Methyl 6-deoxy-6-iodo-2,3,4-tri-0-benzoyl-a-D-glucopyranoside (3).7,8 
Methyl 6-deoxy-6-iodo-a-D-glucopyranoside (2, 10.00 g, 32.89 mmol) dissolved in 
anhydr. pyridine (65 mL) and anhydr. CH2CI2 (65 mL) was treated with benzoyl chloride 
(17.0 mL, 146.58 mmol, 4.46 equiv.) at 0 °C with stirring. After adding benzoyl chloride the 
mixture was allowed to warm to ambient temperature and stirring was continued at this 
SI-3 
temperature for 16 h. The reaction mixture was evaporated and the residue was dissolved 
in EtOAc (500 mL), subsequently extracted with water (2 x 100 mL), aq. citric acid solution 
(2 x 100 mL), satd. aq. sodium carbonate solution (2 x 100 mL), the organic phase was 
dried (MgSOJ, evaporated and chromatographed (adsorbent: 250 g silica gel, eluent: 
hexanes : EtOAc 9 :1 ) . The title tribenzoate was crystallized from hexanes, 17.22 g (85 
%). Rf: 0.30, hexanes : EtOAc 7 : 3, R,: 0.75, toluene : APrOH 7 : 3. Mp. 104.6-106.1 °C 
(lit.7'8 value: 103-106 °C). The 1H and 13C NMR spectra of the above product were in full 
agreement with the published ones.8 
(£/Z)-5,6-Dideoxy-2,3,4-tri-0-benzoyl-D-xy/o-hex-5-enose oxime (5)9 and methyl 6-
deoxy-2,3,4-tri-0-benzoyl-a-D-glucopyranoside (6)10 
1. activated zinc 
various solvents 
sonication 
40-60 °C, 4-5 h 
> 
B z O " ( / = X 
BzO 't)Bz 2. NHjOH.HCI, Na2CO, I —
 4 x = ° 
H 2 0 , C H 2 C I 2 3 U 5 X = N O H 
0-65% yield 27-85% yield 
NH4CI (2.17 g, 40.60 mmol, 10 equiv.) CeCI311 (0.050 g, 0.20 mmol, 0.05 equiv.) and 
activated zinc (2.65 g, 40.60 mmol, 10 equiv.) in THF (10 mL) was allowed to react in an 
ultrasonic bath at 40 °C for 15 min. Methyl 6-deoxy-6-iodo-2,3,4-tri-0-benzoyl-a-D-
glucopyranoside 3 (2.50 g, 4.06 mmol) was dissolved in THF (60 mL) and poured into the 
zinc slurry and sonication was continued. This solution was often mixed with a spatula at 
the beginning of the reaction to prevent the coagulation of zinc dust. After 2 h MeOH (10 
mL) and after an additional 1 h water (1 mL) were added to the reaction mixture to dissolve 
the zinc salts from the zinc surface. After 4 h sonication the mixture was chilled in an ice-
bath, filtered, washed with EtOAc (150 mL), dried (CaCI2), evaporated in vacuo and the 
resulting aldehyde 4 (Rf: 0.30, hexanes: EtOAc 7 :3) was used without purification directly 
for the next step. The crude aldehyde 4 was dissolved in CH2CI2 (200 mL), satd. aq. 
Na2C03 (100 mL) and NH2OH HCI (1.50 g, 21.59 mmol, 5.32 equiv.) were added and the 
resulting heterogeneous mixture was vigorously stirred for 16 h at rt. The layers were 
separated, the organic layer was dried (CaCI2), evaporated and chromatographed 
(adsorbent: 30 g silica gel, eluent: hexanes : EtOAc 9 :1) to give the title oily oximes (1 : 
1 mixture of E/Z isomers, 1.057 g, 55 %, R,: 0.53, 0.60, hexanes : EtOAc 1 : 1 ) . The 
application of HgCI2 in lieu of CeCI3 in MeCN gave a slightly higher yield (65 %, see Table 
1). The IR, 1H and 13C NMR spectra of the above product were in full agreement with the 
published ones.9 
Along with the oxime the 6-deoxy derivative (6)10 could also be isolated {R,: 0.30, 
hexanes : EtOAc 7 :3 ,R , \ 0.65, toluene : /-PrOH 7 : 3 , mp 145.5-146.5 °C, lit.10 value 139-
140 °C) in variable amounts in different solvents (see Table 1). 
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Table 1. Yields of compounds 5 and 6 in the zinc-mediated reaction of 6-deoxy-6-iodo 
derivative 3 
Solvent(s) and reaction conditions Yield of oxime 
5, % 
Yield of 6-deoxy 
derivative 6, % 
THF : MeOH : H20 70 : 10 :1, 10 equiv. Zn, 0.05 
equiv. CeCI3, 10 equiv. NH4CI, sonication at 40 °C, 4 h 
55 32 
neat THF, 10 equiv. Zn, 0.05 equiv. CeCI3, 10 equiv. 
NH4CI, sonication at 40 °C, 4 h 
60 30 
MeCN : MeOH : H20 50 : 2.5 : 2.5, 10 equiv. Zn, 0.05 
equiv. HgCI2, 10 equiv. NH4CI, sonication at 40 °C for 
30 min then reflux for 30 min and this cycle was 
repeated for 5 h 
65 27 
neat dioxane, 10 equiv. Zn, 0.05 equiv. CeCI3, 10 
equiv. NH4CI, sonication at 40 °C, 4 h 
12 75 
neat DMF, 10 equiv. Zn, 0.05 equiv. CeCI3, 10 equiv. 
NH4CI, sonication at 40 °C, 4 h 
0 85 
neat MeCN, 10 equiv. Zn, 0.05 equiv. CeCI3,10 equiv. 
NH4CI, sonication at 40 °C, 4 h 
0 85 
neat acetone, 10 equiv. Zn, 0.05 equiv. CeCI3, 10 
equiv. NH4CI, sonication at 40 °C, 4 h 
0 85 
neat di-/-propyl ether, 10 equiv. Zn, 0.05 equiv. CeCI3, 
10 equiv. NH4CI, sonication at 40 °C, 4 h 
0 85 
(3S,4/?,5S,6S,8S)-8-(Benzyloxymethyl)-9-oxa-1-azabicyclo[4.2.1]nonane-3,4,5-triyl 
tribenzoate (8) 
BnOCH2CHO, toluene 
4Â mol. sieves, 110 °C, 20 h 
28% overall yield 
OBn 
—I NaBH3CN, dioxane, MeOH 
7X = CH2NHOH^ pH=1.4-1.5, rt, 45 min 
,\OBz 
OBz 
SI-5 
To a stirred solution of oxime 5 (3.44 g, 7.27 mmol) in dioxane (300 mL) and MeOH 
(300 mL) was added NaBH3CN (2.74 g, 43.60 mmol, 6 equiv.) while the solution was 
carefully treated with HCI/dioxane (1.7 M, -30 mL) to maintain the pH between 1.4-1.5 
using a combined pH glass electrode for organic solutions. After approximately 45 min, 
when the reduction stopped (the pH of the reaction solution did not alter further), the 
solution was evaporated in vacuo, co-evaporated with MeCN (100 mL), the residue was 
dissolved in a mixture of EtOAc (400 mL) and satd. aq. Na2C03 solution (300 mL), the 
organic phase was washed with additional Na2C03 solution (300 mL), water (300 mL) and 
brine (300 mL), dried (MgSOJ and evaporated in vacuo. If the reaction solution still 
contains some starting material 5 (TLC), subsequent NaBH3CN (2.74 g, 43.60 mmol, 6 
equiv.) has to be added and the pH must be maintained for a repeated 30 min period. The 
unstable hydroxylamine 7 was used immediately without any further purification to avoid 
its decomposition. Rf: 0.60, hexanes : EtOAc 1 : 1 ; TLC-MS (m/z): 476 (100%, [M+H]+), 
498 (12, [M+Na]+). 
The above hydroxylamine 7 was dissolved in dry toluene (250 mL) and treated with 
freshly prepared 2-(benzyloxy)acetaldehyde (2 equiv.) in the presence of 4 A molecular 
sieves and a Dean-Stark water trap. After stirring at 110 °C for 20 h, the solution was 
filtered, evaporated in vacuo and co-evaporated with MeCN (3 x 50 mL). The residue was 
purified by silica gel column chromatography [eluent: 0-5% (v/v) Et20 in CH2CI2] to give the 
title cycloaddition product 8 as a pale yellow oil (1.22 g, 28% overall yield). 
R,: 0.33, CH2CI2: Et20 95 : 5. 
[ot]D: -26 (c=0.5, MeOH). 
IR (CaF2, thin film): 990 (w), 1026 (m), 1069 (m), 1096 (s), 
1315 (m), 1451 (m), 1493 (w), 1584 (w), 1601 (w), 1724 (s), 
3057 (w) cm"1. 
1H NMR (500 MHz, CDCI3, 8, ppm) 2.25 (1H, ddd, J67b# = 
8.7 Hz, J7a7b = 13.5 Hz, J7b8# = 4.6 Hz, H-7b); 2.96 (1H, 
ddd, J67a. = 2.8 Hz, J7a7b = 13.5 Hz, J7a8. = 8.6 Hz, H-7a); 
3.14 (1H, dd, J2a2b = 14.1 Hz, J2a3 = 7.7 Hz, H-2a); 3.41 
(1H, dd, J8 r a = 6.4 Hz, JVarb = 9.4 Hz, H-1 'a); 3.60 (1H, dd, 
J 8 r b = 7.3 Hz, J r a r b = 9.4 Hz, H-1'b); 3.75 (1H, m, H-8); 
4.24 (1H, dd, J2a2b = 14.1 Hz, J2b3 = 5.5 Hz, H-2b); 4.57 
(1H, d, J2,a2,b = 11.9 Hz, H-2'a); 4.66 (1H, d, J2.a2,b= 11.9 
Hz, H-2'b); 4.86 (1H, ddd, J5e = 5.8 Hz, J67b# = 8.7 Hz, J67a. = 2.8 Hz, H-6); 5.66 (1H, dd, 
J45 = 8.1 Hz, J56 = 5.8 Hz, H-5); 5.84 (1H, ddd, J2a3 = 7.7 Hz, J2b3 = 5.5 Hz, J34 = 9.4 Hz, 
H-3); 5.99 (1H,'dd, J3A = 9.4 Hz, J45 = 8.1 Hz, H-4); 7.37 (14H, m, arom.); 7.90 (6H, m, 
arom.). 
13C NMR (126 MHz, CDCI3, 5, ppm) 32.8 (C-7); 59.1 (C-2); 67.6 (C-8); 69.1 (C-3); 72.6 (C-
4); 73.1 (C-1'); 73.2 (C-5); 73.4 (C-2'); 77.1 (C-6); 127.7-128.3 (arom.); 129.0 (arom. Cq); 
1177 (w), 1261 (s), 1278 (s), 
2859 (w), 2942 (w), 3030 (w), 
Sl-6 
129.1 (arom. Cq); 133.0 (arom.); 133.1 (arom.); 133.2 (arom.);138.0 (arom. C ); 165 1 
(CO); 165.1 (CO); 165.5 (CO). 
NOESY (connected protons, relative to the 9-oxa-1-azabicyclo[4.2.1]nonane skeleton) 
top-face: H-3/H-2b; H-5/H-6; H-6/H-7b; 
bottom-face: H-7a/H-8/H-4; H-8/H-2a/H-4. 
LRMS (m/z): 608 (100%, [M+H]+), 630 (25, [M+Na]+). 
HRMS (FAB, glycerol): calcd. for C36H34N08+ [M+H]+ m/z608.22789, found m/z608.2310. 
Anal, calcd. for C36H33N08 (607.649) C, 71.16; H, 5.47; N, 2.31; found C, 71.03; H, 5 59" 
N, 2.48%. 
Methyl 4,6-0-benzylidene-2,3-di-0-benzoyl-a- and ß-D-galactopyranoside (10a and 
10ß) 
C6H5-< V O 
0 \ )AA'0ME 
HO ÖH 
9a, 9ß 
O—\ 
BzCI, py, CH2CI2 C 6 H 5 — ( V o 
0-25 °C, 4 h 
90% yield 
BzO ÖBz 
10a, 10ß 
Methyl 4,6-O-benzylidene-D-galactopyranoside (9, 5.00 g, 17.7 mmol)12 was 
dissolved in a mixture of dry CH2CI2 (40 mL) and pyridine (10 mL) then benzoyl chloride (5 
ml_) was added dropwise to the ice-cooled solution. The reaction mixture was stirred for 
4 h at room temperature then ice was added. The cooled mixture was extracted with 0.1 
M HCI, then successively washed with satd. NaHC03 solution and water, dried (MgSOJ 
and evaporated to dryness. The crude product was dissolved in chloroform and 
precipitated with hexanes (amorphous foam, 7.80 g, 90%). A small amount was further 
purified by silica gel column chromatography (hexanes: EtOAc 85:15) and the mixture was 
separated into anomers. 
a-anomer (10a): amorphous foam. 
R,: 0.10, hexanes : EtOAc 7 : 3. 
[a]D: +182 (c=0.75, CHCI3). 
aF2, thin film): 952 (w), 995 (m), 1028 (s), 1071 (m), 1099 (s), 1112 (s) 1181 im) 
(w), 1275 (s), 1317 (m), 1399 (w), 1411 (w), 1452 (m), 1585 (w), 1602 (w) 1727 (s) 
A«#\ OACC fV\r \*i\ /^m"' V /» V /> 
IR (C . 
1212 
2864 (w), 3065 (br w) cm 
SI-7 
7? 
1H NMR (CDCI3, 8, ppm): 3.35 (3H, s, OCH3); 3.79 (1H, s, H-5); 4.03 (1H, d, J6a6b = 12.8 
Hz, H-6a); 4.24 (1H, d, J6a6b = 12.8 Hz, H-6b); 4.55 (1H, s, H-4); 5.19 (1H, d, J, 2 = 2.2 Hz, 
H-1); 5.48 (1H, s, CHPh); 5.70 (2H, m, H-2 and H-3); 7.14-7.92 (15H, m, arom.). 
13C NMR (CDCI3, 8, ppm): 55.6 (OCH3); 62.2 (C-5); 68.8 (C-2); 69.1 (C-6); 69.2 (C-3); 74.2 
(C-4); 98.1 (C-1); 100.6 (CHPh); 126.1-133.1 (arom.); 165.9 and 168.1 (CO). 
LRMS (m/z): 513.1 (100%, [M+Na+]). 
Anal, calcd. for C28H2608 (490.501) C, 68.56; H, 5.34; found C, 68.72; H, 5.25%. 
P-anomer (10(3): amorphous foam. 
Rf: 0.17, hexanes : EtOAc 7 : 3. 
[a]D: +165 (c=0.7, CHCI3). 
IR (CaF2, thin film): 952 (w), 1013 (m), 1028 (m), 1071 (m), 1082 (m), 1107 (s), 1154 (m), 
1176 (m), 1197 (w), 1278 (s), 1315 (m), 1415 (w), 1451 (m), 1601 (w), 1724 (s), 2855 (w), 
3064 (br w) cm"1. 
1H NMR (CDCI3,8, ppm): 3.44 (3H, s, OCH3); 3.56 (1H, s, H-5); 4.03 (1H, d, J6a6b=12.2 Hz, 
H-6a); 4.30 (1H, d, J6a6b=12.2 Hz, H-6b); 4.49 (1H, d, J34 = 3.8 Hz, H-4); 4.58 (1H, d, J12 
= 8.1 Hz, H-1); 5.30 (1H, dd, J23 = 10.8 Hz, J34 = 3.8 Hz, H-3); 5.45 (1H, s, CHPh); 5.78 
(1H, dd, J1i2 = 8.1, J2,3 = 10.8 Hz, H-2); 7.20-7.91 (15H, m, arom.). 
13C NMR (CDCI3,8, ppm): 56.5 (OCH3); 66.4 (C-5); 68.9 (C-6); 69.0 (C-2); 72.7 (C-3); 73.5 
(C-4); 100.7 (CHPh); 101.9 (C-1); 126.1-133.3 (arom.); 165.2 and 166.1 (CO). 
LRMS (m/z): 513.1 (100%, [M+Na+]). 
Anal, calcd. for C28H2608 (490.501) C, 68.56; H, 5.34; found C, 68.43; H, 5.40%. 
Methyl 6-bromo-6-deoxy-2,3,4-tri-0-benzoyl-a- and p-D-galactopyranoside (11 a and 
11(3) 
NBS, BaC03 
CHCI3, CICH2CH2CI 
65 °C, 3 h 
70% yield 
BzO OBz 
10a, 10p 
BzO OBz 
11a,11P 
SI-8 
A suspension containing methyl 4,6-benzylidene-2,3-di-0-benzoyl-D-
galactopyranoside (10,6.60 g, 13.5 mmol), NBS (3.18 g, 17.8 mmol) and barium carbonate 
(2.80 g, 14.10 mmol) in a mixture of chloroform (165 mL) and 1,2-dichloroethane (25 mL) 
was stirred under reflux for 3 h. The suspension was filtered and the filtrate was 
evaporated to dryness. The residue was dissolved in diethyl ether (50 mL), washed with 
water (3 x 10 mL), dried (MgSOJ and evaporated to dryness. The syrup was dissolved in 
chloroform and precipitated with hexane (amorphous foam, 5.30 g, 70 %). A small amount 
was further purified by column chromatography (hexanes : EtOAc 9 : 1 ) and the mixture 
was separated into anomers. 
a-anomer (11a): amorphous foam. 
R,: 0.16, hexanes : EtOAc 9 : 1 . 
[a]D: +195 (c=0.70, CHCI3) 
IR (CaF2, thin film): 974 (w), 1000 (w), 1026 (m), 1068 (s), 1093 (s), 1106 (s) 1177 (w) 
1207 (w), 1261 (s), 1283 (s), 1315 (w), 1451 (w), 1601 (w), 1724 (w), 2972 (w), 3059 (wj 
cm"1. 
1H NMR (CDCI3, 8, ppm): 3.39-3.40 (2H, m, H-6a and H-6b); 3.44 (3H, s, OCHaV 4 36 (1H 
t. J5& = Js,eb = 6-5 Hz, H-5); 5.23 (1H, d, Ju = 3.6 Hz, H-1); 5.57 (1H, dd, J?3 = 10 8 J ' 
= 3.6 Hz, H-3); 5.87 (1H, dd, J1i2 = 3.6 Hz, J2,3 = 10.8 H-2); 5.92 (1H, d, J3 . = 3 6 Hz' H-4V 
7.13-8.00 (15H, m, arom.). ' ' 
13C NMR (CDCI3, 8, ppm): 29.3 (C-6); 55.8 (OCH3); 68.4 (C-2); 69.1 (C-3); 69 4 (C-5V 69 8 
(C-4); 97.6 (C-1); 128.2-133.6 (arom.); 165.4, 165.5 and 166.0 (CO). 
LRMS (m/z): 590.9 (100%, [M(79Br)+Na+]), 592.9 (94, [M(81Br)+Na+]). 
Anal, calcd. for C28H25Br08 (569.397) C, 59.06; H, 4.43; Br, 14.03, found C 55 87"H 4 59-
Br, 14.35%. ' ' ' ' ' 
P-anomer (11P): amorphous foam. 
R,: 0.23, hexanes : EtOAc 9 : 1 . 
[a]D: +79 (c=0.75, CHCI3). 
IR (CaF2, thin film): 953 (w), 1027 (m), 1046 (m), 1069 (m), 1097 (s) 1105 (s) 1124 (ml 
1177 (w), 1280 (S), 1270 (s), 1315 (w), 1451 (w), 1601 (w), 1724 (s), 2966 (brw) 3062 for 
w) cm'1. 
1H NMR (CDCI3, 8, ppm): 3.42-3.49 (2H, m, H-6a and H-6b); 3.55 (3H, s, OCH3); 4.10 (1H, 
SI-9 
t, J56a = J56b = 6.9 Hz, H-5); 4.66 (1H, d, J, 2 = 7.9 Hz, H-1); 5.50 (1H, dd, J23= 10.3 Hz, J34 
= 3.2 Hz, H-3); 5.68 (1H, dd, J, 2 = 7.9 Hz, J23 = 10.3 Hz, H-2); 5.94 (1H, d, J34 = 3.2 Hz, 
H-4); 7.15-8.0 (15H, m, arom.). 
13C NMR (CDCI3, 5, ppm): 28.5 (C-6); 57.3 (OCH3); 68.6 (C-4); 69.5 (C-2); 71.7 (C-3); 74.0 
(C-5); 102.3 (C-1); 128.3-133.6 (arom.); 165.3 and 165.4 (CO). 
LRMS (m/z)\590.9 (100%, [M(79Br)+Na+]), 593.0 (95, [M(81Br)+Na+]). 
Anal, calcd. for C28H25Br08 (569.397) C, 59.06; H, 4.43; Br, 14.03, found C, 55.95; H, 4.64; 
Br, 14.24%. 
2,3,4-Tri-Obenzoyl-5,6-dideoxy-L-arab/T7o-hex-5-enose oxime (13) 
A suspension of zinc dust (5.20 g, 93.2 mmol), NH4CI (8.80 g, 93.20 mmol) and a 
catalytical amount of CeCI311 were sonicated in a mixture of MeOH (50 mL) and THF (70 
mL) for 15 min. Afterthis pretreatment period methyl 6-bromo-6-deoxy-2,3,4-tri-0-benzoyl-
D-galactopyranoside (11, 5.20 g, 9.3 mmol) was added to the reaction mixture. After 3 h 
sonication at 40 °C the reaction was complete, the suspension was filtered, and 
evaporated to dryness. The residue was dissolved in Et20 (30 mL), extracted with water 
( 3 x 1 0 mL) and dried (MgS04). The crude aldehyde 12 was used without further 
purification in the following reaction. The mixture of the above ethereal solution and water 
(30 mL) was cooled in an ice bath and NH2OH HCI (4.44 g, 93.00 mmol) was added. A 
solution of K2C03 (10.20 g, 93.0 mmol) in water (20 mL) was added dropwise to the 
reaction mixture and stirred for 16 h. The organic layer was separated, washed with water 
( 2 x 5 mL), dried (MgSOJ and concentrated. The residue was subjected to column 
chromatography (hexanes: EtOAc 85:15) to yield a sirupy product (3.20 g, 72 %, E : Z = 
2 :1 , based on the integral intensities of proton H-6a in the 1H NMR spectrum of the isomer 
mixture). 
R f : 0.18, 0.23 (E/Z), hexanes : EtOAc 8 : 2. 
IR (CaF2, thin film): 943 (w), 1026 (m), 1069 (m), 1096 (s), 1107 (m), 1263 (s), 1107 (s), 
1177 (w), 1263 (s), 1316 (m), 1451 (m), 1584 (w), 1601 (w), 1724 (s), 2931 (w), 3063 (w), 
3434 (br w) cm"1. 
11a, 11 p C 12 X=0 13 X=NOH 
SI-10 
1H NMR (CDCI3,5, ppm): 5.34 (0.33 H, d, J5,6a = 11.1 Hz, H-6a); 5.40 (0.67 H, d J,R = 10 1 
Hz, H-6a); (1H, d, J6a,6b = 17.1 Hz, H-6b) 6.00 (4H, m, H-2, H-3, H-4 and H-5); 7 46 (10 H 
m, H-1, arom.); 8.03 (6 H, m, arom.). 
13C NMR (CDCI3, 8, ppm): 66.1 (C-2Z); 69.6 (C-2E); 72.2 (C-4Z); 72.9 (C-4PV 73 1 FC-3 V 
73.3 (C-3e); 120.6 (C-6Z); 121.1 (C-6E); 128.3-133.4 (arom.); 131.2 (C-5F) 131 7 C-5 V 
145.8 (C-1E); 147.0 (C-1Z); 165.1 and 165.5 (CO). ' 1 Z ' ' 
LRMS (m/z): 474.0 (50%, [M+H+]), 496.1 (63, [M+Na+]). 
Anal, calcd. for C27H23N07 (473.474) C, 68.49; H, 4.90; N, 2.96; found C, 68 30" H 5 1ft-
N, 3.20%. ' ' ' ' 
(3S,4/?,5/?,6S,8/?)-8-(Methoxycarbonyl)-9-oxa-1 -aza-bicyclo[4.2.1 ]nonane-3 4 5-trivl 
tribenzoate (15) and (3S,4/?,5/?,6R,8S)-8-(methoxy-carbonyl)-9-oxa-1-aza-bicyclo-
[4.2.1 ]nonane-3,4,5-triyl tribenzoate (16) 
BzO 
BzO" "OBz 
13 X = CH=NOH 
M e 0 2 C C H 0 , 4A mol. sieves, Me0 2 0 / , 
toluene, 110 °C, 20 h, 
or n - B u - ^ N - M e 1 7 
\=J © 
PF^ 
Me 14 X = CH2NHOH Z l a 
(a) NaBH3CN, MeOH o r 18 
pH=1.4-1.5, rt, 1 h w c© pFr 
64-79% yield 
OBz 
15 
OBz 
16 
To a stirred solution of oxime 13 (0.300 g, 0.63 mmol) in MeOH (100 mL) was added 
NaBH3CN (0.240 g, 3.79 mmol, 6 equiv.). The pH of the solution was maintained between 
1.4-1.5 with 1 M HCI/MeOH and monitored either by a combined pH glass electrode for 
organic solutions or by the indicator bromocresol green. After 1 h the solution was 
evaporated in vacuo (the pH of the reaction mixture did not change further), co-evaporated 
to dryness with toluene (3 x 20 mL). The residue was dissolved in Et20 (100 mL) and the 
ethereal solution was washed with aq. 0.1 M HCI (20 mL), satd. aq. Na2C03 solution (2 x 
50 mL) and distilled water (3 x 50 mL), dried (MgSOJ and evaporated to dryness in vacuo. 
The obtained hydroxylamine 14 was used without any further purification. R f : 0.35, 
hexanes : EtOAc 1 :1 ; TLC-MS (m/z): 476 (100%, [M+H]+), 498 (12, [M+Na]+). 
The above crude product was dissolved in dry toluene (100 mL) and treated with 
freshly prepared methyl glyoxylate13 (0.140 g, 1.57 mmol, 2.5 equiv.) in the presence of 4 
A molecular sieves. After stirring at 110 °C for 16 h, the solution was filtered, evaporated 
in vacuo and co-evaporated with toluene (3 x 50 mL). The residue was purified by column 
chromatography (hexanes : EtOAc 85 :15). The diastereoisomers were separated in an 
SI-11 
additional run of silica gel column chromatography (hexanes : /-PrOH 10 : 0.5) to give the 
cycloaddition product 15 (0.165 g) and 16 (0.055 g) in 64 % overall yield in a ratio of 3 :1. 
In another experiment, starting from oxime 13 (0.120 g, 0.25 mmol), the cycloaddition step 
was carried out in achiral ionic solvent 1-n-butyl-3-methyl-1 H-imidazol-3-ium 
hexafluorophosphate 17 and the reaction yielded diastereoisomers 15 (0.088 g) and 16 
(0.011 g) in 72 % overall yield in a ratio of 8 :1. 
When the same reaction sequence was repeated with 13 (0.100 g, 0.21 mmol,) in 
chiral ionic solvent (S)-3-ethyl-1-(1-hydroxypropan-2-yl)-1 H-imidazol-3-ium 
hexafluorophosphate 181 diastereoisomer 15 (0.088 g) was obtained in 79 % overall yield. 
In the 1H NMR spectrum of this sample there were only very small signals, beyond the 
signals of 15, originating from unidentified impurities. 
Compound 15: 
R,: 0.20, hexanes : EtOAc 7 : 3. 
[a]D: +170 (c=0.55, CHCI3). 
IR (CaF2, thin film): 985 (w), 1001 (w), 1027 (m), 1070 (m), 1095 (m), 1108 (m), 1120 (m), 
1177 (w), 1263 (s), 1280 (s), 1451 (w), 1601 (w), 1725 (s), 2952 (w) 3062 (w) cm"1. 
1H NMR (CDCI3> 5, ppm): 2.69 (1H, ddd, J67a = 6.0 Hz, J7a8 = 
10.1 Hz, J7a7b= 13.3 Hz, H-7a); 2.84 (1H, ddd, J67b= 8.9 Hz, j7b8 
= 8.9 Hz, J7a7b= 13.3 Hz, H-7b); 3.22 (1H, dd, JZa3 = 8.99 Hz, 
J2a2b= 13.3 Hz, H-2a); 3.75 (3H, s, OCH3); 4.00 (1H, dd, J2b3 = 
4.0 Hz, J2a2b = 13.3 Hz, H-2b); 4.76 (1H, m, H-6); 4.35 (1H, dd, 
J7a8= 10.1 Hz, J7b8= 8.9 Hz, H-8);5.68 (1H, dd, J45 = 4.0 Hz, J56 
= 1.85 Hz, H-5); 5.87 (1H, dd, J34 = 9.48 Hz, J45 = 4.0 Hz, H-4); 
6.15 (1H, ddd, J2a3= 8.99 Hz, J2b3= 4.0 Hz, J34 = 9.48 Hz, H-3); 
7.17-8.10 (15H, m, arom. CH). 
13C NMR (CDCl3,5, ppm): 32.9 (C-7); 52.6 (OCH3); 54.1 (C-2); 67.1 (C-3); 68.2 (C-8); 72.0 
(C-5); 72.1 (C-4); 81.2 (C-6); 128.2-133.4 (arom.); 165.0, 165.4, 165.8 (3 x benzoyl CO); 
168.1 (acetyl CO). 
NOESY (connected protons, relative to the 9-oxa-1-azabicyclo[4.2.1]nonane skeleton) 
top-face: H-2b/H-3; H-6/H-7b/H-8 
bottom-face: H-2a/H-4/H-5/H-7a. 
LRMS (m/z): 546.3 (100%, [M+H+]), 568.2 (37, [M+Na+]). 
HRMS (FAB, glycerol): calcd. for C30H28NO9+ [M+H]+ m/z546.17586, found m/z546.17794. 
Anal, calcd. for C30H27NO9 (545.537) C, 66.05; H, 4.99; N, 2.57; found C, 65.87; H, 5.18; 
SI-12 
N, 2.73%. 
Compound 16: 
R,: 0.26, hexanes : EtOAc 7 : 3. 
[<x]D: +7 (c=0.5, CHCy. 
IR (CaF2, thin film): 944 (w), 1026 (m), 1069 (m), 1096 (s), 1120 (s), 1178 (m) 1219 (ml 
1265 (s), 1316 (m), 1451 (m), 1470 (m), 1585 (w), 1602 (w), 1730 (s), 2849 (s) 2916 (sl 
3062 (w), 3259 (br w) cm1. " v 
1H NMR (500 MHz, C6D6, 8, ppm) 2.11 (1H, ddd, J67a = 9.6 Hz 
J7a,7b = 13.7 Hz J7a8 = 9.3 Hz, H-7a); 3.21 (1H, ddd, J67b = 5.5 
Hz, J7b7a = 13.7 Hz, J7b8 = 10.1 Hz, H-7b); 3.34 (3H, s, Me); 3.64 
(1H, dd, J2a,2b = 15.0 Hz, J2b3 = 3.7 Hz, H-2b); 3.72 (1H, dd, J2a2b 
= 15.0 Hz, J2a3 = 10.0 Hz, H-2a); 4.09 (1H, dd, J7a8 = 9.3 Hz, 
J7b,8 = 10.1 Hz, H-8); 4.71 (1H, ddd, J5,6 = 7.9 Hz, J67a = 9.6 Hz, 
J6,7b = 5.5 Hz, H-6); 6.10 (1H, dd, J45 = 4.9 Hz, J56 = 7.9 Hz, H-
5); 6.25 (1H, dd, J34 = 10.2 Hz, J45 = 4.9 Hz, H-4); 6.30 (1H 
ddd, J2b3 = 3.7 Hz, j2 a 3 = 10.0 Hz, j 3 4 = 10.2 Hz, H-3); 6.92 (9H, 
arom.); 8.24 (2H, m, arom.). 
13C NMR (CDCI3, 8, ppm): 35.0 (C-7), 53.3 (OCH3), 56.2 (C-2), 66.6 (C-8), 68 8 (C-31 69 7 
(C-5), 72.5 (C-4), 78.4 (C-6), 128.5-133.9 (arom.), 165.5, 168.6 (CO). ' 
NOESY (connected protons, relative to the 9-oxa-1-azabicyclo[4.2.1]nonane skeletonl 
top-face: H-2b/H-3; H-3/H-7b ; 
bottom-face:H-2a/H-4; H-4/H-5/H-6; H-5/H-6/H-7a; H-7a/H-8. 
LRMS (m/z)\ 546.1 (100%, [M+H+]), 568.1 (39, [M+Na+]). 
HRMS (FAB, glycerol): calcd. for C30H28NO9+ [M+H]+ m/z546.17586, found m/z546.17821 
Anal, calcd. for C30H27NO9 (545.537) C, 66.05; H, 4.99; N, 2.57; found C, 66.19; H, 5.21; 
N, 2.78%. 
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m I . . .M Ml I I I • I | I 11 l| • • I • | I 11 I I " * 1 ' " 1 ' I 
176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16 8 
ppm 
r 
Acquisition Time (sec) 2.1823 Comment Imported from UXNMR. 
Solvent CHLOROFORM-D Frequency (MHz) 500.13 
Nucleus 1H Number of Transients 32 Oriqinal Points Count 16384 Points Count 16384 
Pulse Sequence test Sweep Width (Hz) 7507.51 Temperature (deqree C) 27.000 
co 
i 
O) 
X J L 
MeO 
,\OBz 
OBz 
16 
OBz 
H-8 H-2a 
J L « -J .,.> À 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I II I I II II I II 'I I ' I 'I I I I II I I I ' • I ' ' I I I ' ' 
5.0 4.5 4.0 3.5 3.0 2.5 2.0 
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i 
8.5 8.0 7.5 7.0 6.5 6.0 
"rTr" 
5.5 ppm 
Acquisition Time (sec) 1.1108 I Comment Imported from UXNMR. 
Frequency (MHz) 125.77 Nucleus 13C 
Number of Transients 2048 I Oriainal Points Count 32768 Points Count 32768 Pulse Sequence test2 
Solvent CHLOROFORM-D Sweep Width (Hz) 29498.53 Temperature (deqree C) 27.000 
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 
ppm 
